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Fertility is the most important factor controlling mammalian reproduction. Bull
fertility, ability of the sperm to fertilize and activate the egg, and support embryonic
development is crucial for early development. Similarly, the hormonal environment of
the embryo also plays a critical role in successful embryonic development. We know that
molecular health of the sperm as well as progesterone enhancing the development of the
embryo is important for early development and implantation. The gaps in the knowledge
base are 1) how early mammalian embryo development is paternally affected is not fully
clear and 2) how progesterone improves the survival of the transferred embryo in the
uterus still remains elusive. The central hypothesis was that low expression of MHC1 and
Magel2 would cause a dysfunction in early embryo development and that progesterone
will increase the survivability of the embryo via its associations with TNF-alpha and
PGF2alpha. The objectives of this study were to 1) determine the expression of mhc1 and
magel2 in single in vivo and in vitro blastocysts derived from low fertility and high
fertility sires as well as to determine main pathways by which protein products of these
genes regulate early development, and 2) identify the role of progesterone in regulating

TNF-alpha and PGF2alpha. To accomplish these goals, we performed real time reverse
transcriptase reaction and bioinformatics approaches, and ELISA and commercially
available radioimmunoassay kits, respectively. The results of the experiments showed
that 1) expression of mhcI transcripts were greater in high fertility in vivo embryos
compared to their low fertility in vivo counterparts. Magel2 results showed an increase (P
≤ 0.05) in expression levels of high fertility in vivo embryos compared to their high
fertility in vitro counterparts. Low fertility in vivo embryos had higher expression than
high fertility in vitro embryos as well.
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CHAPTER I
INTRODUCTION

Literature Review
There are multiple abnormalities that can occur that may disrupt fertility and
thereby damage gametes, processes involved in fertilization or early embryos. The
interest in bovine infertility began in the 1950s after the introduction of artificial
insemination. Reproductive success is economically essential for the producers and
affects the costs of products for consumers as well. Infertility accounts for major
economic losses in the cattle industry where some owners can see 10 to 30% of their herd
affected by reproductive issues [1]. In order for an operation to be economically viable a
cow has to become pregnant, deliver and wean healthy calves. A major drawback in the
cattle industry is that commercial farmers take enormous losses when cows fail to keep a
12-month calving interval. The anestrous postpartum interval is a major factor
contributing to cows failing to become pregnant and calving on a yearly interval [2]. In
addition, a short luteal phase can further delay the interval from calving to conception
and usually occurs following the first post-partum ovulation [3, 4]. In order for a cow to
maintain pregnancy the viability of both parental gametes are essential and a suitable
uterine environment are necessary.
The causes of infertility vary greatly in bovine regarding both males and females,
such as congenital and functional irregularities, as well as infections [5-7]. At one time,
1

female infertility was believed to be the primary factor limiting efficient production of
offspring; however, recent studies have revealed male infertility may lead to the collapse
of the breeding system [8-10]. Male infertility may occur when spermatozoa cannot
conceive or produce offspring. Sperm fertility traits are classified into two groups,
compensatory and non-compensatory. Compensatory infertility can be overcome by
increasing sperm numbers; however, non-compensatory infertility is subject to
morphological or genetic defects that cannot be overcome by increasing sperm cell
numbers [11]. Non-compensatory infertility possess a problem for livestock producers
and researchers alike as these sperm cells can look morphologically normal yet still have
sub-par fertility, suggesting that the issue lies within the genetic make-up of the cell.
Molecular defects in the sperm caused by DNA damage can hinder developmental
competencies of the gamete [12, 13]. The fertility of a male can be influenced by the
quality of sperm that it produces; which in turn can be influenced by the DNA integrity.
Sperm DNA integrity is critical for accurate transmission of paternal genetic information.
The integrity of DNA can influence sperm quality and male infertility [14]. Agarwal and
Said [15] suggested that disturbances in the organization of the genomic material in
sperm nuclei are negatively correlated with the fertility potential of spermatozoa, either in
vivo or in vitro. The consequences of DNA damage are also supported by [16] who
indicated in their study that if >30% of sperm DNA is damaged, natural pregnancy is not
possible. Bull fertility is suggested to be moderately heritable [17]; therefore, the ability
to develop genetic markers to help predict fertility earlier would decrease or eradicate
male infertility as a potential issue. Although bull fertility is essential, embryonic
retention is also extremely important to the success of a pregnancy.
2

In 2010, 591,000 in vivo-derived bovine embryos were transferred globally and
253,671 of them were transferred in North America [18]. Even with this technique being
used commercially for the last 30 years, embryonic retention remains a main factor
limiting application of embryo transfer by producers. Following the transfer, embryo
mortality can be more than 40% during the first 18 days of gestation in sheep and dairy
cattle [19, 20]. Because progesterone plays an essential role in pregnancy, it is widely
viewed as critical for embryonic survival and for establishment of pregnancy [21-24].
Gene Expression: Paternal Influence
Major Histocompatability Complex
Mammalian development starts with fertilization of matured oocyte by
spermatozoa, followed by formation of the zygote, the early embryos and the blastocyst.
Once attachment is complete, the embryo is firstly called a conceptus then a fetus during
its development. In both gametes, oocyte and sperm cells, transcription and translation
are silent prior to fertilization. Followed by fertilization, maternally expressed RNAs and
proteins are gradually degraded at the certain time, which is termed maternal-embryonic
transition (MET) [25-27]. Indeed, the expression of embryonic derived genes gradually
increases during MET, which occurs in a different time among mammals in a speciesspecific manner [27]. The developmentally competent blastocyst communicates to the
endometrium to advance attachment using newly synthesized transcripts and proteins.
Since an embryo can carry both sets of maternal and paternal genes, it may be considered
an antigen or allogen by the maternal immune system [28, 29]. This semi-allogeneic
conceptus is a stranger that needs to by-pass several immunological and endocrinological
barriers in the maternal immune system [30]. This by passing only occurs when the cell
3

surface antigens of embryos that have been newly transcribed are similar to those of the
endometrial cells. In this manner the well-studied cell surface antigens, major
histocompability complex genes (MHC), are fundamentally related to immune response
in graft rejection arising in immune response against transplanted tissue or organ [31, 32].
Three classes of MHC have been identified as MHCI, MHCII, and MHCIII in
mammals [33, 34]. Major Histocompatability Gene Complex express highly polymorphic
cell surface antigens, playing an essential role in immune response by distinguish the
differences between self vs. non-self molecules including graft rejection at the fetomaternal intersection [35]. Classes I and II molecules present peptides to T lymphocytes.
MHCI are expressed by almost all nucleated cells except red blood cells whereas MHCII
is encoded by only antigen presenting cells (APCs); dendritic cells, macrophages, and B
lymphocytes [36] [37, 38] [39, 40] . MHCI that is classified into two groups as classical
and non-classical MHCI molecules presents proteins that are derived from either its own
cells or intracellular pathogens to the cytotoxic/CD8+ T cells (CTL) [41] [42]. It is
believed that the lack of classical MHC I expression is a protection of placenta against
immune attacks [43]. In addition to classical MHCI, non-classical MHCI has less
polymorphism and different functions that protection of embryos from immune cells such
as CD4+ T cells and natural killer (NK) [44, 45]. The gene complex was first identified in
mice and then in humans as human leukocyte antigen (HLA) [46]. Afterwards, their roles
in the graft rejection or survival were demonstrated [47]. Following this, the preattachment embryo development (ped) gene, as well as its location and expression -Qa-2
antigen- in mice was described [48, 49]. Previous studies showed that the Qa-2 protein is
transcribed in different stages of mouse embryos and its expression enhances embryo
4

survival [50-52]. The human leukocyte gene-G (HLA-G) gene was described in 1987
[53] as a functional homolog of the mouse ped gene [35, 54]. Thus, the impact of the
expression of HLA-G during fertilization, pre-attachment development and feto-maternal
interaction in human reproduction was revealed [54].
The importance of in vitro fertilization (IVF) has accelerated over the past twenty
years in mammals. According to International Embryo Transfer Society (IETS) data, the
transfer of in vitro produced bovine embryos was -more than a half million (823,160) in
2007 [55]. Selection of the best embryo to transfer to the mother still relies on
morphological assessment of embryo quality. Conventional methods including oocyte
selection and grading and conditions of culture media [55] are insufficient to noninvasively identify the embryos with high developmental competency. Another selection
method is to identify viable embryos by determining amount of soluble HLA-G in culture
media [56, 57]. However, molecular mechanisms of how non-classical MHCI regulates
developmental potential and how paternal heredity of these MHC antigen genes are
expressed during embryonic development are still unknown in mammals, especially in
cattle [58].
Attachment
The endometrium plays a critical role prior to attachment and during pregnancy,
which has recently been revealed as an early sensor of in vitro embryo manipulation
technologies [59]. In this study, the differentially expressed genes were shown in the
endometrium from d 20 of gestation, including the embryos generated via in vivo, in vitro
and somatic nuclear transfection (SCNT). According to their results, the endometrial
gene expression in the presence of the embryos generated via artificial insemination (AI),
5

IVF and SCNT were different from one another. Gene expressions in Caruncles (C) and
Intercaruncular areas (IC) were significantly different in the AI, IVF and SCNT based
pregnancies. Therefore, the lack of gene expression and biological functions in the
embryos derived by SCNT might be an indicator that how important the paternal side is
for a pregnancy to carry to term [59].
Immune Response During Pregnancy
Inflammation is the most common acute immune response against foreign
organisms. During maternal recognition of an embryo, cell population and the secretion
levels might change when fetal classical MHCI transcripts trigger the maternal immunity
response, which can cause an immune/inflammatory response [60]. It was shown that
lymphocyte cell population, trophoblast cell apoptosis in placentomes and cytokines that
are being produced are significantly different between classical MHCI compatible and
incompatible pregnancies at parturition [43]. Since fetal classical MHCI may trigger
maternal immune response, the expression of classical MHCI should be shut down for
normal placental retention and fetal survival. A high abortion rate between d 34 and 63%
of SCNT pregnancies in bovine was determined because of abnormal expression of
classical MHCI genes by trophoblast cells [43].
Human and Murine MHC
Human Leukocyte Antigen G improves embryo quality and pregnancy rates in
human [54, 56]. The MHC genes have been determined in several species so far; human
(HLA), mouse (H-2), and bovine (BoLA) [61].
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Developmental competency of an embryo requires synthesis of new transcripts
and proteins in order for proper attachment and maintenance of pregnancy. The major
role of HLA-G proteins is to protect the placenta against natural killer cell (NK) attacks
by immunosuppression [62] and to increase the survival of the embryo during
development [62]. The effects of HLA-G were shown in fertilization, pre-attachment
development [54], and feto-maternal interaction in human reproduction [63]. Several
studies showed that the expression of HLA-G in d 3 embryos, in extravillous trophoblast
cells [64], included a positive correlation between HLA-G levels of the embryos and their
cleavage, attachment as well as pregnancy rates in humans [65, 66]. Previous studies
showed that measurement of HLA-G levels might be a sufficient non-invasive method to
facilitate identification of implantable embryos to the recipient [56, 57]. Research also
revealed that the ped gene in the mouse is 97% homologous with the bola gene in bovine
[67]; however, bovine and human genomes are more similar than the mouse and human
genomes [68].
According to the HLA Nomenclature system, the proposed HLA alleles should
contain at least a four digit name, which indicates it allelic group, specific HLA protein,
DNA substitution within the coding region, differences in non-coding region with the
changes in expression, respectively [69]. Human leukocyte antigen classical and nonclassical genes with their information are listed in Table 1. 1.
Bovine MHC
In contrast to humans and mice, classification of the gene complex and their
expression with their localization are not well known in bovine. Nomenclature for MHC
genes and alleles in bovine were first suggested by the International Society for Animal
7

Genetics (ISAG) in 2002 [70]. The goal of the Veterinary Immunology Committee (VIC)
of the International Union of Immunological Societies (IUIS) is to establish a common
framework and guidelines for MHC terminology in any species in the committee report.
Major histocompatibility complex gene I alleles would be named as a single non-assigned
series as BoLA-N*; however, non-classical class I alleles would begin BoLA-N*50001 to
distinguish them from the classical MHCI alleles [71]. In 2006, the first four nonclassical MHCI loci were submitted to Genbank with accession numbers DQ140357Dq140378; however, they are unofficially called NC1-NC4 [71]. There are 9 known nonclassical MHCI loci (NC1-4) that have been identified thus far (listed in Table. 1.2).
The expression of classical and non-classical MHCI genes was found in bovine
trophoblast cells [72]. Normally, bovine placenta codes MHCI antigens in course of the
third trimester of pregnancy [73]. According to [71], there might be a balance between
classical and non-classical MHCI transcript levels. It was shown that 34 to 79% of the
transcripts belonged to non-classical MHCI whereas 21 to 66% of the transcripts were
derived from classical MHCI [71].
According to [74] non-classical MHCI is highly expressed in metaphase II stage
oocytes, presumptive zygotes and 10% of blastocyst cDNA sequences during preattachment embryo development in cattle. However, it has been suggested that the nonclassical MHCI NC1 gene, which has a number of splice variants [58], could encode both
membrane bound and soluble forms of the protein and thus influence immunotolerance in
cattle [71].
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MAGE Like Protein 2
Imprinted Genes
Traditionally, gene expression is regulated by what is now known as Mendel’s
Inheritance Law. This theory consisted of two laws; the law of segregation and the law of
independent assortment [75]. The first law, the law of segregation, states that an offspring
will develop their alleles through the combination of both parents donating a single allele.
The second law, the law of assortment, states that alleles of different genes assort
independently of one another during gamete formation [76]. However, imprinted genes
do not follow the customary Mendelian genetic law as there are no dominant or recessive
genes. Unlike the Mendelian law, imprinted genes are solely expressed from one parent
as the cell may only use the copy from the mother or a copy from the father [77-79]. The
nature of imprinted genes is epigenetic and is controlled by DNA methylation and histone
modifications; essentially with two stages involved, erasure and establishment during the
epigenetic reprogramming of gametogenesis [79].
Epigenetics attempts to elucidate how gene expression can be regulated without
changing the genetic code. DNA methylation is one biological modification within
epigenetics that helps modify DNA gene expression by attaching a methyl group to a
cytosine in the DNA code, which occurs globally over the genome [80, 81]. Areas in the
genome that have a high number of cytosine and guanine nucleotides, known as CpG
islands, are located near transcription start sites and it is speculated that genes are
repressed [82, 83]. In mammals, DNA methyltransferases (DNMT) are a group of
enzymes that are responsible for the transfer of methyl groups to the DNA. There are four
DNMT’s that put the initial pattern of methyl groups in place on the DNA sequence and
9

one DNMT that works as a maintenance DNMT, copying the methylation from an
existing strand of DNA to a new strand through replication[84, 85]. Specific patterns of
gene expression and repression are important in the control of mammalian reproduction;
which suggests a link between DNA methylation and male fertility. Sperm chromatin is a
combination of DNA and two nucleoproteins, histones and protamines, which help
package DNA and control gene expression. There are five families of histones (H1/H5,
H2a, H2B, H3, and H4) [86-88] and two types of protamines (P1 and P2) [89]. Recently,
improper methylation of histone variant 3.3 (H3.3), histone 4 (H4), and P1 are thought to
cause abnormal chromatin structure or gene expression, which may prevent fertilization
and/or early embryonic development [90-92].
Gametogenesis, fertilization, and early development of the embryo go through
genome wide-methylation changes, called epigenetic reprogramming [93], with
demethylation and de novo methylation processes. Once the reprogramming of the
paternal and maternal germline occurs, it is passed on to the zygote after fertilization.
When there is a modification in DNA it is logical to assume that there would be a change
in the structure of the chromatin. Lee and Lee [94] proposed that when DNA methylation
occurs, tighter wrapping of the DNA around the histone occurs which changes the
structure of the chromatin and blocks transcription factors from binding [95].
Prader-Willi Syndrome
Mage like protein 2 (MAGEL2) is a protein, which is maternally imprinted and
paternally expressed. MAGE proteins are able to interact with transcription factors and
nuclear receptors and have been known to have an effect on downstream gene activity
[96]. Imprinted genes are vulnerable during the pre-attachment stage and changes in the
10

methylation states brought on as a consequence of in vitro culture may cause a change in
expression of the paternally expressed genes [78]. MAGEL2 is one gene in a cluster of
four that is responsible for the Prader-Willi Syndrome (PWS).
Prader-Willi Syndrome is a disorder involving imprinting genes in the long arm of
chromosome 15 [97]. This deficiency affects reproduction by causing hypogonadism in
males with deficient magel2 expression in the hypothalamus [97, 98]. This syndrome
may be linked to the improper methylation patterns associated with both paternal and
maternal imprinted genes [99]. A deleted section of de novo methylation patterns on the
paternal chromosome affect 70% of individuals who have PWS, where 30% of
individuals have a maternal imprinted defect [100]. As magel2 is maternally imprinted,
but paternally expressed methylation defects on either chromosome could potentially
affect its expression. If the maternal chromosome has a deleted region than the gene will
not be inherited or if improper establishment of the paternal methylation pattern takes
place then magel2 will still be affected. The NDN promoter region is a control region for
magel2 that is methylated in individuals with PWS, this methylation would repress the
expression of magel2 [101]. A region on chromosome 15 where all of the possible
deletions for imprinted genes occur that could cause PWS is called the PWS shortest
region of overlap (PWS-SRO) [102]. This region is required for the maintenance of
paternal methylation patterns. If the PWS-SRO is deleted, NDN becomes methylated and
magel2 is repressed. This theory of methylation patterns was justified when sperm that
were missing the PWS-SRO region were used to fertilize normal oocytes and found that
NDN promoters were methylated and magel2 expression was abnormal [103].
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During embryogenesis, Magel2 expression is restricted to the embryonic
hypothalamus as well as the genital tubercle and placenta [104]. Although both magel2
and null magel2 mice have been able to mate, it has been noted that the mating frequency
of null magel2 males declined by 16 weeks and eventually stopped [104]. A lack of the
magel2 gene caused developmental delay and a decrease in sex hormones [105]. Other
studies that have been conducted conclude that female Magel2-null mice display
extended and irregular estrous cycles, while males showed a decrease in testosterone
levels, and reduced olfactory preference for female odors [106]. Magel2 may also
indirectly play a role in infertility via PWS as this disease causes extreme obesity in both
animals and humans. Research has shown that magel2 null mice weighed less at
weaning, but increased their weight gain dramatically [107]. It has been well documented
that obesity and infertility go hand- in- hand as it can cause erectile dysfunction and
hormonal dysfunctions [108-110]. This loss of fertility has been determined to be caused
by a dysfunction or disruption in follicular stimulating hormone and inhibin B levels,
which could be used as a reliable marker for fertility potential with males lacking the
magel2 gene [111].
Progesterone’s Role in the Survival of the Embryo
Successful pregnancy in mammals requires both a viable embryo and a receptive
endometrium. Synchronous signalling between the endometrium and embryo during the
pre-attachment period is critical for normal embryo development, attachment of the
embryo, and placentation [112-114]. Attachment is debatably the most essential stage in
the establishment of pregnancy. Failed attachment is a major limiting factor with embryo
losses of more than 40% during the first 18 days of gestation in cattle and sheep [115].
12

Similar to other domestic ruminants, aattachment takes place at the hatched blastocyst
stage in cattle, however, attachment occurs differently in ruminants compared to
mammals due to lack of trophoblast invasion.
The attachment of the conceptus involves a complex series of events occurring
over time that depends on the interaction between the mother and conceptus. Attachment
is also highly dependent on the degree of synchrony between the embryo and the
endometrial lining of the uterus, which is influenced by proteins, hormones, and other
metabolic and physiological factors [116-118]. In each of these events, hormonal
regulation is required; however, progesterone plays an integral part in the synchronization
of the embryo and endometrium. Progesterone plays such an essential role in pregnancy,
that it is widely viewed as critical for embryonic survival and for the establishment and
maintenance of pregnancy [21-24].
Progesterone Production
Progesterone is known as the hormone of pregnancy and is a primary reproductive
hormone that helps regulate reproduction. It belongs to a class of hormones called
progestogens and, similar to all other steroid hormones, is synthesized from cholesterol
[119]. There are several sources of progesterone in the body; the corpus luteum (CL), the
adrenal glands, and the placenta during pregnancy, however, the CL is the greatest source
of progesterone [120, 121]. The larger cells of granulosa origin are the principal
progesterone secreting cells in the CL because they contain large amounts of cholesterol
that can be converted into progesterone [122, 123].
Progesterone is produced by the stimulation of the gonadotropins on a cell’s
membrane. The gonadotropin that targets the large granulosa cells of the CL is luteinizing
13

hormone (LH) [124]. A series of enzyme reactions are then completed to allow
progesterone to be released into the bloodstream until it comes upon its target cell.
Progesterone then passes through the cell membrane and cytoplasm and binds to the
protein receptor in the nucleus [125]. Once this binding occurs the protein-receptor
complex stimulates the synthesis of messenger RNA (mRNA). The mRNA then travels to
the cytoplasm, where it directs the synthesis of specific proteins and the new protein is
responsible for the action of progesterone on the target tissue [126, 127].
Progesterone also partially governs the length of the estrous cycle. During the
follicular phase concentrations of progesterone are low and greater concentrations of
estradiol act on the hypothalamus to stimulate the release of LH. After ovulation the CL
develops and high circulating concentrations of progesterone restrict the secretion of LH.
Progesterone blocks GnRH from the hypothalamus [128]. In the pituitary, progesterone
reduces the number of receptors for GnRH [129] by down-regulating mRNA encoding
the receptor for GnRH ([130]. Additionally, progesterone decreases the amount of LH
and FSH released in response to the decrease of GnRH receptors [131].
Progesterone’s Role in Embryo Attachment
It appears that the most important condition required for embryo survival is a
fully functional corpus luteum producing sufficient amounts of progesterone. Attachment
is the establishment of pregnancy and is characterized by three main components; 1) the
pre-attachment period; 2) apposition; and 3) adhesion. It is important to understand
progesterone’s role in inhibiting luteolysis and its role in the maternal recognition of
pregnancy during the pre-attachment period. These two steps are critical before the
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establishment of pregnancy can occur and are both involved with the protein InterferonTau (IFN-T).
Pre-Attachment Period
Inhibition of Luteolysis:
Luteolysis occurs when an embryo is not detected [132]. For luteolysis to occur
there is a loss of secretion of progesterone and a loss of cells that comprise the CL [133].
The entire estrous cycle is dependent on the uterus and its pulsatile secretion of
prostaglandin F2α (PGF2α) from the endometrium that results in the functional and
structural destruction of the CL [134]. It has been well established that progesterone
released from the CL in necessary for the maintenance of pregnancy [112, 116-118]. If
progesterone concentrations decrease, estrogen concentrations will increase causing an
increase in oxytocin concentrations as well. It is also known that progesterone decreases
the amount of oxytocin and its number of receptors, which have a positive feedback
system with PGF2α [135]. Therefore, if progesterone decreases, oxytocin increases and
induces more PGF2α to be released from the endometrium. The establishment and
maintenance of pregnancy requires a prolonged CL and higher concentrations of
progesterone [117]. In order for this to occur the conceptus must protect the CL from
luteolysis or suppress luteolysis.
The suppression of luteolysis occurs when a conceptus releases the IFN-T protein.
Interferon-Tau is a member of the type 1 interferons and binds to IFN receptors [136].
Bovine IFN-T is found in cattle and is secreted by the cells of the trophectoderm of the
blastocyst [137]. Interferon-Tau inhibits PGF2α by releasing a prostaglandin synthesis
inhibitor [113] as well as down regulating estrogen and oxytocin receptors [117]. By
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these actions, IFN-T is able to help keep higher progesterone concentrations in the system
and prolong the life of the CL. Asselin et al. [138] also suggested that a protection against
luteolysis occurs by IFN-T converting the PGF2α secreted from the uterus into PGE2α; a
luteotropic prostaglandin.
Maternal Recognition of Pregnancy:
The major cause of pre-attachment issues is the difficulties of signaling between
the embryo and mother, in which the failure of the conceptus to communicate with the
mother will cause luteolytic secretions [139]. Progesterone is responsible for regulating
multiple cytokines that help synchronize the embryo and endometrium, however, IFN-T is
one of the most important. By suppressing the release of PGF2α from the mother, IFN-T
not only protects the CL from regression, but it is also the first signal from the conceptus
to the mother for the recognition of pregnancy. A study conducted by [140] found a
strong positive correlation between progesterone concentrations and the synthesis of IFNT

by the conceptus. This finding would suggest that increasing progesterone

concentrations in the cow would be beneficial to embryo survival as the more
progesterone that is produced by the CL the more IFN-T that can be produced by the
conceptus telling the mother that it is ready to be accepted by her. This is supported by
[141] who suggested that inadequate IFN-T production may be due to low progesterone
concentrations in the uterus. It has also been discovered that heifers and ewes with lower
concentrations of progesterone in the early luteal phase had retarded concepti that
secreted less IFN-T [142, 143].
In addition, IFN-T aids embryo survival by helping suppressing the immune
system of the mother [144]. As can be expected, the embryo may be seen by the mother
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as a foreign cell and the immune system may work to remove it. However, Walker et al.
[145] found that IFN-T binds to receptors that activate the Janus kinase-signal transducer
and activator of transcription pathway that allows a range of interferon products to be
produced. Interferon-Tau and other interferons provide a localized immune system
suppression to allow the embryo to survive in the uterus. Pontzer et al.[146] also found
that IFN-T suppresses the maternal immune response to embryo antigens, thereby
allowing conceptus survival. Progesterone is also involved with the maternal immune
system as it is a potential inhibitor for the embryotoxic cytokine, Tumor Necrosis Factorα (TNF-α)that is secreted by the macrophages of the mother [147]. Miller and Hunt [148]
suggested that progesterone is a potent inhibitor of TNF-α mRNA and TNF-α protein
production in mouse macrophages in vitro. This finding is supported by Vegeto et al.
[149] who found that progesterone inhibited apoptosis induced by TNF-α in macrophage
cells, suggesting a role in regulating immune response.
Early Embryo Development:
In both lactating dairy cows and heifers, there is a strong positive association
between the time that concentrations of progesterone increase in plasma and embryonic
survival [150]. Follicular development is of extreme importance as inadequate follicular
development reduces the ability of fertilized oocytes to develop to the blastocyst stage.
Inskeep et al. [151] found that abnormal follicular dynamics may be explained by a
failure of normal luteal function that affects progesterone production. Harper and
Publicover [152] discussed the possibility that progesterone is present at the ovum and
the acrosomal enzymes of the sperm are able to be activated by the stimulation of
progesterone. After fertilization is complete, cleavage of the embryos begin. Cleavage is
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the mitotic divisions of the zygote from a one celled embryo to a multicellular embryo.
The zygote divides into blastomeres until it is considered a morula, and shortly
afterwards it transforms into a blastocyst (Figure 1.1). Montero-Padro et al. [153] found
that the cleavage rate of cells in sheep had better survival rates when injected with bovine
somatotropin. This would suggest that increased progesterone concentrations would help
cleavage rates as somatotropin can favor fertility through its effect on the CL [154]. On
the other hand, [151] discussed the possibility of low concentrations of progesterone
causing early embryonic death. The timing of fertilization is important as delayed
fertilization may result in issues with synchrony between the embryo and the mother,
however, the main cause for asynchrony is altered secretory patterns of progesterone
[143].
Blastocysts are important because they contain two cell types; 1) trophoectoderm;
and 2) inner-cell mass. The inner cell mass will develop into the fetus; however, the
trophoectoderm is extremely important as it is the cell layer that secretes the first signal
of maternal recognition, IFN-T, as previously discussed [155]. The blastocyst stage is also
important because a layer of trohpoblast cells develop that will help orient the blastocyst
over the endometrium and the zona pellucida is lost which allows the conceptus to
elongate. The expansion of the trophoblast provides an increased placental surface area
to enable maternal:conceptus cross-talk and nutrient exchange that are essential for the
survival of the conceptus [156]. Once this is complete, the second phase of attachment
can occur, apposition.
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Apposition
During apposition, contact between the trophoblastic cells and the microvilli of
the uterine cells are established and there is a lot of morphological change that occurs
during this period on both the fetal and maternal sides [157]. In cattle, there is an
increase in vascular activity and crumpling of the surface of the epithelium occurs to
create caruncles. Progesterone concentrations are high at this point and decrease the
muscular activity of the uterus, but aid in the proliferation of the uterine epithelium to
create the caruncles [158]. Between the caruncles the trophoblast develops villi that
penetrate into the uterine glands, which causes a semi-attachment between the conceptus
and the uterus [137, 159] .
Adhesion
The last phase of attachment is adhesion, in which the trophoblast adheres firmly
to the endometrium. The formation of syncytium (cells with a singular nucleus) occurs as
a consequence of the fusion of the maternal columnar epithelial cells and the conceptus
trophoblastic binucleate cells [160]. This is the adhesion stage which ends the attachment
process and allows for placentation to occur. Although progesterone acts via the uterus to
stimulate blastocyst survival and growth, the specific genes and physiological
mechanisms regulated by progesterone are not fully understood. Spencer et al. [161]
found that progesterone both positively and negatively regulates expression of genes in
the endometrium, and progesterone and IFN-T regulate a number of genes, particularly in
the endometrial epithelium. In addition to the up- regulating genes, progesterone also
down-regulates a number of genes in the endometrium that can be revealed by treatment
of animals with an antiprogestin [161]. A study conducted by [162] discovered that the
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balance of proteases and their inhibitors is likely required to modify the endometrial
lining and trophoblast during apposition and adhesion phases of attachment. This is
important because Spencer et al. [161] discussed that progesterone helps regulate the
genes that are responsible for producing the correct amount of proteases and inhibitors
that would modify the endometrial lining.
Progesterone is deeply involved in each of the attachment stages and any altering
of the hormone would cause embryonic loss. Progesterone’s role in the inhibition of
luteolysis, the early embryo development, the maternal recognition of pregnancy, and the
receptivity of the uterus are all integral to the success of attachment. The role of
progesterone in embryonic loss has been extensively explored and some results are still
controversial, however, what is known is that progesterone is accepted as having a
pivotal role in the establishment of pregnancy. The gap in knowledge of mechanisms and
factors regulating conceptus implantation in mammals remains to be discovered,
however, proper conceptus development in early gestation is crucial for attachment and
maintaining pregnancy.
Exogenous Progesterone Supplementation
As progesterone is deemed to be necessary for embryo survival, the use of
exogenous progesterone supplementation could potentially be an ideal answer to low
concentrations of progesterone. However, the use of exogenous progesterone
supplementation has produced contradictory results. Multiple studies [163-166] have
been published to establish supplemental progesterone as beneficial; however, timing,
quantity, and lactating status appear to be critical components when examining the
results. Robinson et al. [167] found that inserting a progesterone releasing intra-vaginal
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device (PRID) between d 5 and d 12 post insemination improved pregnancy rates by
30%. However, in that same study the use of supplemental progesterone d 10 to d 17 post
insemination caused reduced endogenous concentration of progesterone to be released.
Similar studies have been repeated to support the theory that timing of supplemental
progesterone is important [168, 169]. The first 5 d of gestation appear to be the most
influential timing for the use of exogenous progesterone. This is in line with the natural
increase in progesterone that would influence embryonic growth and survival [143]. An
increase in progesterone would allow for sufficient release of IFN-T from the conceptus;
allowing for maternal recognition.
Several studies [170, 171] have suggested that the use of supplemental
progesterone reduces endogenous release of the steroid. Suppression of endogenous
progesterone may be caused by the down regulation of progesterone (Cook 1990).
Progesterone is able to regulate its own synthesis by affecting the enzymes that are
involved in luteal steroidogenesis [172], suggesting that if greater concentrations of
progesterone are detected a decrease in progesterone synthesis will occur. This selfregulation has been found to reduce the endogenous production of progesterone [143,
167, 171].
Lactating cows may possibly have lower concentration of progesterone due to the
increased metabolism of progesterone. Studies [173, 174] suggest that higher feed intake
required by lactating cows cause the liver to metabolize the steroid quicker than in nonlactating animals. This theory would allow supplemental progesterone to increase
concentration of systemic progesterone, thereby increasing the chance of embryo
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survival. Several studies support this idea as increased pregnancy rates were observed in
lactating cows supplied with exogenous progesterone [175-177].
Induced Progesterone Production
It is important to ensure timely ovulation in relation to the time of insemination as
sperm can only live in the female reproductive tract for 24 hr [178]. Gonadotropin
releasing hormone could reduce variation in the timing of ovulation[179]. Other data
have shown that injections of GnRH increases ovulation frequency in non-cycling and
cycling, suckled beef cows [180, 181]. Several earlier studies [182-184] demonstrated
that treatment with GnRH improved pregnancy rates. Mee et al [185]suggested that
GnRH might act on the developing CL to promote small luteal cells to large luteal cells.
As luteal cells are known to produce progesterone, an increase in large luteal cell
numbers could potentially increase concentrations of progesterone allowing for increased
conception rates.
Large luteal-phase follicles have previously been shown to be capable of
responding to human chorionic gonadotropin (hCG) by production of luteinized
structures[186]. Administration of hCG to heifers on d 4 to 7 increased mean plasma
progesterone concentrations during the estrous cycle [187, 188]. These data indicate the
presence of a large luteal-phase follicle that is capable of ovulating in response to hCG.
Whether the hCG induced increase in plasma progesterone concentration resulted from
enhanced progesterone secretion by the CL present at the time of hCG administration,
from additional progesterone secretion from the induced luteal structure, or from a
combination of these is not known. Human chorionic gonadotropin is also speculated to
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increase concentrations of progesterone by behaving similar to LH. After binding to LH
receptors, hCG causes small luteal cells to increase progesterone synthesis [189].
Progesterone’s Role in the Immune System
The immune system is an intricate system and is the body’s first line of defense
against disease. In pregnancy, immune responses are autoimmune (maternal response to
pregnancy) or alloimmune (maternal response to male genetic contribution)[190]. As
discussed previously, the embryo can be seen as an allogen in the body that the maternal
immune system may attack [29]. Progesterone’s role in inhibiting the maternal immune
response has been studies extensively [191-193]. The blocking of progesterone binding
sites by RU 486, a progesterone antagonist, caused abortion in various mammalian
species [194]. Two isoforms of progesterone receptors have been identified, PR-A and
PR-B [195]. Szekers-Bartho et al. [196] suggested that due to the increase in
progesterone responsiveness of pregnancy lymphocytes, it seems plausible that
lymphocytes express binding sites for progesterone. Multiple studies have identified
impaired sexual behavior, neuroendocrine gonadotropin regulation, anovulation, and
uterine dysfunction with the absence of progesterone receptors in female mice [197-199].
Progesterone inhibits lymphocyte proliferation by increasing concentrations of Cs2+ and
prolonged activation of protein kinase C (PKC); these are known as the two main signals
in T-cell differentiation and proliferation [200].
As discussed earlier, non-classical MHCI is an antigen that may play an important
role in maternal-fetal immune tolerance [29]. Non-classical MHCI have been reported to
inhibit natural killer cell lysis and cytotoxic T-cell activity [201-203]. After progesterone
receptor activation, binding occurs to a specific DNA sequence, which results in the
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transcription of target genes [204]. Progesterone was observed to have an up-regulatory
effect on the non-classical MHCI (HLA-G) gene [205].
An immune response for cytokine production can be classified into two groups:
Th1 or Th2. Th1 cytokines are deleterious to pregnancy while Th2 cytokines have a
beneficial effect [206]. The altered balance between these two cytokines appear to be
important in pregnancy and that Th2 cytokines should be greater in number than Th1
cytokines [207]. A Th1 cytokine, tumor necrosis factor- α (TNF- α), has been reported to
hinder embryo development, attachment and trophoblast proliferation[208]. However,
recent studies suggest that TNF- α may have ambiguous role as increased concentrations
of progesterone may lead to luteotropic functions [171, 209].

Table 1.1

Human MHC Classical and Non-Classical I Genes

HLA Class I
Classical

Non-classical

Gene

A

B

C

E

F

G

Alleles

1,601

2,125

1,102

10

22

46

Proteins

1,176

1,641

808

3

4

15

Nulls

80

63

25

0

0

2
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Table 1.2

Non-classical MHC I alleles

NC1*00101

N*50001, Gene X

NC1*00101SV

NC1*00201

AY188807 Holstein

Holmes et al, Immunogenetics 55:193202 2003

AY188807 Holstein

Holmes et al, Immunogenetics 55:193202 2003
Araibi et al, Virology 353:174-183 2006

N*50002, AH19-D DQ140369 Holstein

NC1*00202SV NC1*00202

JN792884

Angus cross

Davies et al, Am J Reprod Immunol
55:188-200 2006
Unpublished

NC1*00301

N*50003, AH12-D DQ140370 Holstein

Davies et al, Am J Reprod Immunol
55:188-200 2006

NC1*00401

N*50501, AH11-E DQ140371 Holstein

Davies et al, Am J Reprod Immunol
55:188-200 2006

NC1*00501

NC1*00501

JN792885

Angus cross

Unpublished

NC1*00601

NC1*00601

JN792886

Angus cross

Unpublished

NC1*00701

NC1*00701

JN792887

Angus cross

Unpublished

NC2*00101

N*50101, HD15

X80936

Holstein

NC2*00102

N*50102, AH19-C, DQ140372, Holstein,
AH11-D
DQ140377 Holstein

NC2*00103

NC2*00103

NC3*00101

N*50201, AH19-K, DQ140373, Holstein
AH11-K
DQ140378

Davies et al, Am J Reprod Immunol
55:188-200 2006

NC4*00101

N*50301, AH12-C DQ140374 Holstein

Davies et al, Am J Reprod Immunol
55:188-200 2006

NC4*00201

N*50401, AH11-G DQ140375 Holstein

Davies et al, Am J Reprod Immunol
55:188-200 2006

NC4*00202

NC4*00202

JN792890

Angus cross

Unpublished

NC4*00301

NC4*00301

JN792891

Angus cross

Unpublished

NC5*00101

NC5*00101

JN792892

Angus cross

Unpublished

JN792888

Angus cross

Ellis et al, Immunogenetics 43:156-159
1996
Davies et al, Am J Reprod Immunol
55:188-200 2006
Unpublished

(According to EMBL-EBI database http://www.ebi.ac.uk/ipd/mhc/bola/nomen_rules.html)

25

Figure 1.1

Stages of Early Embryonic Development [adapted from [210]]
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CHAPTER II
DYNAMICS OF PROGESTERONE, TNF-α AND A METABOLITE OF PGF2α IN
BLOOD PLASMA OF BEEF COWS FOLLOWING EMBRYO TRANSFER

Abstract
Some cytokines are speculated to be regulated by progesterone and can be both
beneficial and detrimental to pregnancy success, depending on the timing and degree of
their expression. The objective of this study was to identify the role of progesterone in
regulating TNF-α and PGF2α. Lactating beef cows received an embryo along with no
treatment (control), controlled internal drug releasing device (CIDR), human chorionic
gonadotropin (hCG), or gonadotropin releasing hormone (GnRH) to assess effects on
tumor necrosis factor-α (TNF-α) and prostaglandin F2α (PGF2α) after transfer of
embryos. Blood samples were taken on d 0 (day of embryo transfer), 7, and 14 for
analysis of progesterone and TNF-α, and on half the animals on d 7 (collected every 15
min for 2 h) and the remaining half on d 14 for PGF2α. Pregnancy rates were 56.2, 62.5,
46.7 and 13.3% for cows in the control, CIDR, hCG and GnRH groups, respectively.
Progesterone was greater (P ≤ 0.05) in cows receiving hCG compared to other groups on
d 7. Mean concentrations of progesterone in each treatment group increased from d 0 to 7
and declined (P ≤ 0.05) from d 7 to 14. Non-pregnant cows had an overall decline in
progesterone and TNF-α from d 0 to 14 (P ≤ 0.05). While increased (P ≤ 0.05)
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concentrations of PGF2α metabolite were seen in pregnant and non-pregnant animals on d
14, however, no difference (P ≥ 0.05) was in overall between the two groups.
Key Words: cattle, TNF-α, PGF2α, progesterone, transferred embryos
Introduction
Progesterone is abundantly reported in the literature as the primary and most
intrinsic hormone associated with embryonic survival during early pregnancy [21-24].
The emphasis in studying progesterone is due to the ability exhibited by progesterone in
regulating uterine receptivity during implantation [211]. Several studies have
demonstrated the benefits of providing progesterone supplementation on the survival of
transferred embryos in cattle [163-166], progesterone on d 7 are also suggested to be
critical to embryo survival [212].
On the other hand, Purcell et al. [115] did not detect beneficial effects on
pregnancy rates by placing controlled internal drug releasing devices (CIDR)
immediately subsequent to embryo transfer in dairy cows. However, our laboratory
observed [177] that inserting a CIDR immediately after transfer enhanced retention rates
in recipient lactating and non-lactating beef cows. A more recent study conducted by our
laboratory showed cows in the control group had increased pregnancy rates in parallel
with increased progesterone during the first week after embryo transfer compared to
treated cattle. An explanation for the disagreement in results may be due to the temporary
decrease in production of endogenous progesterone via CIDR in recipient cows with
sufficient production of progesterone [171]. Therefore, strategies to enhance endogenous
production of progesterone may be an alternative method to increase concentrations of
progesterone.
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Several hormonal treatments have been used to manipulate secretion of
endogenous progesterone in cattle. Gonadotropin releasing hormone (GnRH) is reported
to alter synthesis of progesterone [213] by manipulating growth of the follicle [214] and
number of corpus lutea (CL) [215]. Furthermore, administration of GnRH at the time of
insemination results in increased conception rates in cattle [183, 216, 217]. In addition,
human chorionic gonadotropin (hCG) has also commonly been used in cattle to boost
endogenous concentrations of progesterone in blood [189, 218]. The increase in
progesterone may be a result of the formation of an accessory CL [212, 219, 220] in
addition to promoting growth of the existing CL[220, 221]. Nevertheless, hCG
inconsistently improves pregnancy rates [219, 221-224].
Prostaglandin F2α (PGF2α) is responsible for inducing regression of the CL [225]
and its synthesis by the uterus is regulated by progesterone [226]. In cyclic sheep, loss of
progesterone receptors allows for the uterine release of luteolytic pulses of PGF2α
suggesting an inverse relationship. Tumor necrosis factor alpha (TNF-α) has both
luteotropic and luteolytic functions [209]. Progesterone is considered to be a potent
inhibitor of TNF-α mRNA and TNF-α protein production [148]. The decrease in TNF-α
concentration on d 7 after the transfer of embryos may be associated with the decreased
concentrations of progesterone observed in the non-pregnant animals [171].
Understanding the relationship among PGF2α, TNF-α, and progesterone is critical to
understanding maintenance of pregnancy. Therefore, our objective was to identify the
role of progesterone in regulating TNF-α and PGF2α with a hypothesis that exogenous
progesterone creates a window of time that facilitates synchrony between the embryo and
the uterine environment.
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Materials and Methods
Experimental Design and Hormonal Protocol
The study was approved by the Institutional Animal Care and Use Committee of
Mississippi State University (11-023) and implemented at The Coastal Plain Branch
Experiment Station of Mississippi State University in Newton, MS in the Spring of 2011.
Lactating Angus crossbred cows were synchronized for estrus by receiving a CIDR
(Eazi-Breed™ CIDR®; Zoetis, Madison NJ) for 7 d. One d after removal, all cows (n =
62) received an injection of PGF2a (25 mg IM; Lutalyse; Zoetis). Cows were observed for
estrus four times per d (1 h at each time) during the 80 h post-PGF2a. Following manual
evaluation of the CL via palpation per rectum, all cows exhibiting estrus with a CL
received an embryo in the uterine horn ipsilateral to the CL on 7 d post-estrus (d 0). At
the time of transfer, cows were assigned to 1 of 4 treatments: no further treatment
(Control, n=16), a CIDR insert (CIDR, n=16), an injection of hCG (1000 IU, IM; Sioux
Biochemical, Inc., Sioux Center, IA; hCG, n = 15) or an injection of GnRH (100 µg, IM;
Cystorelin; Merial, Duluth, GA; GnRH, n = 15).
Animals and Embryos
Animals were weighed and body condition scores (scale of 1=emaciated;
9=obese; [227] were assessed by visual appraisal at the beginning of the project at
synchronization. Embryos used in the study were donated by Mississippi State
University. Flushing and freezing of the embryos were performed on d 7 after
insemination. Embryos were a quality grade 1 [20] and a developmental stage 4 and 5;
the embryos were frozen in ethylene glycol and stored in liquid nitrogen until their use.
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The transfer of embryos was performed by an embryo transfer practitioner (Mid-South
Reproductive Services, Baton Rouge, LA).
Collection and Laboratory Analysis of Blood Samples
All samples were collected in 6.0 mL plastic vacutainers with no additives (Fisher
Scientific, Pittsburg, PA). Immediately after collection the samples were stored on ice
until they could be centrifuged for 15 minutes at 1800 ×g, which was followed by long
term storage at -20°C until later analysis. Blood samples for determination of 13,14dihydro-15-keto PGF2α metabolite (PGFM) were collected from half the animals in each
treatment group on d 7 and the remaining half on d 14; samples were collected every 15
min for 2 h on both days. Synthesis of PGF2α in each blood sample was inhibited as
previously described by[228]. Blood samples were collected from all cows on d 0 (day of
transfer), 7, and 14 for analysis of progesterone and TNF-α.
The concentration of progesterone in peripheral blood plasma was determined via
radioimmunoassay that has been validated for use in bovine (Coat-a-Count Progesterone,
Los Angeles, CA) and used according to the manufacturer’s procedure. Plasma samples
were assayed for concentrations of TNF-α via a double antibody radioimmunoassay as
described by [229], with the following changes. Antibody (rabbit anti-bovine TNF-alpha
R7-93) generated against recombinant bovine TNF-α (kindly donated by Ciba-Geigy,
Basel, Switzerland), was used as the primary antibody at a final tube dilution of
1:120,000 and recombinant bovine TNF-α (Kingfisher Biotech, St. Paul, MN) was
radioiodinated and used as the assay tracer. Concentrations of PGFM were measured
using an enzyme-linked immunosorbent assay (ELISA; Oxford Biomedical Research,
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Oxford, MI) and used according to the manufacturer’s instructions. The intra-assay and
inter-assay coefficients of variation were 6.25 and 9.38%, respectively.
Statistical Analysis
Age and body condition score of experimental animals were analyzed using the
GLM procedure (SAS, Inst. Inc., Cary, NC). Concentrations of progesterone, TNF-α and
PGFM in blood were analyzed using the MIXED procedure SAS (SAS Inst., Inc.) with
repeated measures. The repeated measures model for the response plasma hormone
concentrations on d 0, 7 and 14 contained the fixed effect of the treatments and the
repeated factors of day and their corresponding interactions. Least squares means by the
Bonferroni adjustment were analyzed and separated when a protected F test of P ≤ 0.05
was detected. Correlation between progesterone and PGFM concentrations were
performed using the CORR procedure of SAS (SAS Inst., Inc.). All comparisons in the
statistical analysis were established at a 5% level of significance. Throughout results,
LSMeans ± standard errors are presented.
Results and Discussion
Progesterone
Progesterone plays an essential role in pregnancy and is widely viewed as critical
for embryonic survival and establishment of pregnancy [230, 231]. Pregnancy diagnosis
via palpation per rectum at 60 d after transfer of the embryos revealed retention rates of
56.2% (9/16) for the control group, 62.5% (10/16) for the CIDR group, 13.3% (2/15) for
the GnRH group, and 46.6% (7/15) for the hCG group. Pregnant cows had increased (P ≤
0.05) concentrations of progesterone on d 14 compared to non-pregnant cows (Figure
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2.1). However, it is noteworthy that the actual loss of pregnancy cannot be pinpointed to
a specific d. An animal that was pregnant on d 14 may not have maintained the
pregnancy by d 60. This yields the potential for greater concentrations of progesterone
being recorded for that cow due to her pregnancy status at the time of collection, which
would then influence the overall concentration of progesterone for the non-pregnant
group. Therefore, our results are relative to the retention of embryo on d 60. No
differences were observed in body condition scores among cows in the hCG (5.76 ±
0.21), control (5.47 ± 0.18), GnRH (5.68 ± 0.11), and CIDR (5.67 ± 0.49) groups.
Concentrations of progesterone during the two weeks after embryo transfer may
be associated with embryonic retention, as the majority of embryo losses take place
between d 7 and d 14 [171]. There was a significant treatment by pregnancy status
interaction, with cows failing to maintain pregnancy in the hCG group having
significantly greater concentrations of progesterone (P ≤ 0.05) on d 7 (5.40 ± 0.58
ng/mL) and d 14 (2.91 ± 0.61 ng/mL) compared to non-pregnant cows in any other
treatment group on d 7 (2.27 ± 0.63, 2.32 ± 0.68, and 2.57 ± 0.44 ng/mL in control,
CIDR, and GnRH groups, respectively) and on d 14 (0.91 ± 0.63, 0.46 ± 0.44, and 1.24 ±
0.47 ng/mL in control, CIDR, and GnRH groups, respectively). Although non-pregnant
cows in the CIDR group had similar concentrations between d 0 and d 7, a decrease (P ≤
0.05) in the concentration of progesterone occurred from d 7 (2.31 ± 0.68 ng/mL) to 14
(0.46 ± 0.68 ng/mL). Non-pregnant animals in the GnRH group had a decline (P ≤ 0.05)
in progesterone from d 7 (3.34 ± 0.44 ng/mL) to d 14 (1.24 ± 0.47 ng/mL), whereas,
animals in the hCG group had an increase (P ≤ 0.05) from d 0 (2.67 ± 0.59 ng/mL) to d 7
(5.4 ± 0.59 ng/mL), but had a decrease (P ≤ 0.05) in concentration of progesterone from d
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7 (5.4 ± 0.59 ng/mL) to d 14 (2.90 ± 0.62 ng/mL). Conversely, animals that maintained
pregnancy in the hCG group had an increase (P ≤ 0.05) in progesterone from d 0 (2.17 ±
0.46 ng/mL) to d 7 (4.53 ± 0.65 ng/mL). Johnson et al. [232] discovered that treatment
with hCG caused cows to ovulate earlier and have greater progesterone in circulation,
which supports these current data. Human chorionic gonadotropin may increase overall
secretion of progesterone from the primary CL as well as from the induced secondary
luteal structure [188, 232-235].
An overall comparison between pregnant and non-pregnant animals (Figure 2.1)
revealed that both non-pregnant and pregnant cows had an increase (P ≤ 0.05) in
concentration of progesterone from d 0 to d 7 but a decrease (P ≤ 0.05) from d 7 to d 14.
However, only in non-pregnant cows did this result in less (P ≤ 0.05) progesterone on d
14 compared to d 0 when the embryos were transferred.
Concentrations of progesterone in each treatment group were not different at the
time of transfer of the embryos (Figure 2.2) as a result of the previously synchronized
estrus and the examination of the viability and presence of a well-developed CL in all
animals on that day. Concentrations of progesterone decreased (P ≤ 0.05) from d 7 to d
14 in cows from all treatment groups; however, only cows in the GnRH group had a
decreased (P ≤ 0.05) concentration of progesterone on d 14 compared to d 0 (Figure 2.2).
On d 7, cows in the hCG group had increased concentrations of progesterone compared
to animals in all other treatment groups. On d 14, concentrations of progesterone in cows
in the hCG group were only greater (P ≤ 0.05) than those in the GnRH group. Also, cows
in the hCG group were the only ones with an increase (P ≤ 0.05) in progesterone from d 0
to d 7 (Figure 2.2).
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In cows that did not maintain the pregnancy (non-pregnant) and those that did
(pregnant) within each treatment group (Table 2.1) the non-pregnant cows had similar
concentrations of progesterone from d 0 to d 7 in the control, CIDR, and GnRH groups,
however, an increase in progesterone (P ≤ 0.05) was observed in the hCG group. These
results are in agreement with previous results reported by other investigators suggesting
that hCG increases the production of endogenous progesterone [188, 232-235].
All cows that did not maintain pregnancy had decreased (P ≤ 0.05) concentrations
of progesterone from d 7 to d 14. Non-pregnant animals had a decrease (P ≤ 0.05) in
progesterone from d 0 to d 14 and had decreased (P ≤ 0.05) concentrations of
progesterone compared to the pregnant animals on d 14 in the control and CIDR groups.
If maternal recognition of pregnancy does not occur, the release of PGF2α from the uterus
causes a regression of the CL, which decreases the concentration of endogenous
progesterone within the animal, at approximately d 9 of this study. Pregnant cows had
increased (P ≤ 0.05) concentrations of progesterone on d 0 to d 7 and decreased (P ≤
0.05) concentrations of progesterone from d 7 to d 14 in all groups, except the GnRH
group. Cows in the GnRH group may have maintained greater concentrations of
progesterone throughout the study via the ability of GnRH to protect against luteolysis or
disrupt the normal pattern of folliculogenesis [236]. Only cows in the CIDR group had a
decrease (P ≤ 0.05) in progesterone from d 0 to d 14. Pregnant and non-pregnant animals
in the control group had a similar pattern of changes in concentrations of progesterone
compared to animals in the CIDR group; thus, these data are similar to others and those
authors conclude the CIDR did not benefit animals because it did not increase the amount
of progesterone in circulation [115]. The animals in the control group had concentrations
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of progesterone that are greater than the previous studies conducted in our laboratory;
however, it has been reported by our research team that supplementation with exogenous
progesterone via a CIDR may cause some suppression of normal CL growth and reduced
endogenous progesterone secretion in animals under no lack of progesterone stress [167,
171].
Tumor Necrosis Factor α
Concentrations of TNF-α followed the same pattern as concentrations of
progesterone among treatments, with hCG having the greatest concentrations of TNF-α
among the groups. There is a decline (P ≤ 0.05) in concentration of TNF-α in animals in
the hCG group from d 0 to d 14 (Figure 2.3). There is also a greater (P ≤ 0.05)
concentration of TNF-α present in the hCG group compared to the CIDR group on d 0
(Figure 2.3). The decrease (P ≤ 0.05) in TNF-α between d 7 and d 14 also follows the
decrease (P ≤ 0.05) in concentrations of progesterone within the hCG group. The similar
pattern between progesterone and TNF-α suggests a link that allows this hormone and
protein to act congruently [237]. A treatment by pregnancy status interaction was
detected (P ≤ 0.05) (Table 2.2). In non-pregnant cows, concentrations of TNF-α
decreased (P ≤ 0.05) from d 0 to d 14. In pregnant cows in the hCG group,
concentrations of TNF-α on d 14 were increased (P ≤ 0.05) compared to the non-pregnant
cows on d 14 in the hCG group. Similar results were seen in a previous study where
concentrations of TNF-α increased after administration of hCG [238]. Although a
potential link between the gonadotropin and cytokine has been developed via the
Interleukin-6 receptor system, the mechanistic actions remain unknown [238, 239].
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Concentrations of TNF-α decreased (P ≤ 0.05) from d 0 to 14 in non-pregnant
animals (Figure 2.4). Non-pregnant cows also had a greater (P ≤ 0.05) concentration of
TNF-α on d 0 compared to pregnant cows. As treatments had only been administered on
d 0, the non-pregnant animals may have already been in the later luteal phase, which has
been observed to have greater concentrations of TNF-α [240]. Therefore, these animals
may not have been able to maintain pregnancy because of the low concentrations of
progesterone associated with the late luteal phase or concentrations of progesterone were
too low to prevent the embryotoxic effects of TNF-α. However, it is noteworthy that
unlike non-pregnant animals, pregnant cows maintained more consistent concentrations
of TNF-α through the entire experimental period. Interestingly, TNF-α has been
associated with luteolytic properties. Some investigators [241, 242] have suggested that
TNF-α is deleterious to young embryos and promotes the process of luteolysis, thereby
stimulating the release of PGF2α. This however, has been questioned by others [171, 209]
who have suggested that TNF-α may provide both luteolytic and luteotropic tendencies.
These current data supports this theory as concentrations of TNF-α increase throughout
the study in pregnant animals and decreases steadily from d 0 to d 14 in the non-pregnant
group. The greater concentrations of TNF-α seem to be associated with the greater
concentrations of progesterone found in pregnant animals. Although not completely
understood, increased concentrations of progesterone may have been responsible for
inhibiting the luteolytic properties of TNF-α; however, if these greater concentrations of
progesterone did not exist, then perhaps the luteolytic functions of TNF-α took over and
the protein became deleterious to the embryos as previously reported [243, 244].
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Prostaglandin F2α
There were no significant differences in mean concentrations of PGFM (P ≥ 0.05)
among the treatment groups on d 7 (0.30 ± 0.48, 0.37 ± 0.84, 0.33 ± 0.46, 0.43 ± 0.99
pg/mL in control, CIDR, GnRH, and hCG groups, respectively) or d 14 (0.51 ± 0.11, 0.64
± 0.69, 0.55 ± 0.14, 0.62 ± 0.85 pg/mL in control, CIDR, GnRH, and hCG groups,
respectively). There were also no differences in mean concentrations of PGFM between
pregnant and non-pregnant animals within treatment groups. Many studies have
associated increased concentrations of PGF2α with the termination of pregnancy [225], as
PGF2α is released from the uterus to essentially cause luteolysis in cattle. However, in
these current data, animals in both the pregnant and non-pregnant groups had greater (P ≤
0.05) concentrations of PGFM on d 14 compared to d 7, but no difference (P ≥ 0.05) was
seen between the pregnant and non-pregnant groups (Table 2.3).
Prostaglandin F2α is released in pulses from the endometrium of the uterus and
80% of it is metabolized during one passage of the lungs, which helps create a short halflife for PGF2α as well as fluctuations in concentrations [245]. As expected, variation
existed among the six samples collected over the 2 hr period for each cow. These data are
supported by fellow investigators [228, 246] who also reported variations of
concentrations of PGF2α between cyclic and non-cyclic ewes. On both d 7 and d 14 there
were consistently one or two samples within both the pregnant and non-pregnant animals
that were greater (P ≤ 0.05) than the other samples collected from each cow (Table 2.3).
Concentrations of PGFM in pregnant animals were more consistent in comparison with
concentrations observed in non-pregnant cows. Furthermore, concentrations of PGFM in
samples 5 and 6 on d 14 were significantly greater (P ≥ 0.05) in pregnant cows compared
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to non-pregnant cows (Table 2.3). Nevertheless, concentrations of PGFM were not
correlated on either d 7 or d 14 of the study with concentrations of progesterone. These
findings are supported by other investigators [226, 247-250] who found that PGF2α
actually increases during pregnancy. This suggests that the pattern of uterine secretion is
altered during pregnancy and that PGF2α becomes luteo-protective rather than luteolytic
[251]. One possible luteo-protective mechanism for the pregnant animal is to decrease
their sensitivity to the luteolytic effects of PGF2α [252]. Sensitivity may be decreased by
the steady release of PGF2α in pregnant animals, whereas non-pregnant animals have
more variation in their release of PGF2α [253]. This steady release may allow the CL to
become desensitized and the number of PGF2α receptors reduced, which would induce a
more rapid metabolism of PGF2α to the inactive PGFM. A more rapid metabolism may
occur because more PGF2α would remain in the bloodstream after it did not bind to its
receptor and would move quickly through the lungs. Alternatively, along with the steady
secretion of PGF2α, the uterus may receive signals from the conceptus via interferon tau
to induce the release of PGE2, which would consequently reduce the luteolytic effects of
PGF2α [254]. When exposed to PGF2α luteal cells have a rapid increase in intracellular
calcium, which is believed to play a role in the luteolytic effects of PGF2α; however,
PGE2α appears to have the ability to inhibit the increase in calcium caused by PGF2α [255]
and thereby reduce the luteolytic effects of its counterpart.
Conclusions
Concentrations of progesterone on d 14 after the transfer of embryos appears to be
imperative to the survival of transferred embryos. Although treatment with hCG resulted
in the greatest concentration of progesterone, this did not translate to the greatest
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pregnancy rate in this study. In addition, an increase in concentration of progesterone was
positively correlated with TNF-α, perhaps inhibiting the luteolytic effects of TNF-α as
more of these cows maintained pregnancy.
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x,y

2

Controlled internal drug release
Gonadotropin releasing hormone
3
Human chorionic gonadotropin
4
Day of embryo transfer

1

LSMeans and standard errors for concentrations of progesterone (ng/mL) in pregnant and non-pregnant cows within
treatments

Means within the same column lacking a common superscript are significantly different (P ≤ 0.05)
Means within row and within treatment group lacking a common superscript are significantly different (P ≤ 0.05)

a,b,c

Table 2.1
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a,b,c

x,y

LSMeans and standard errors for concentrations of TNF-α (pg/mL) in pregnant and non-pregnant cows within
treatments

Means within the same column lacking a common superscript are significantly different (P ≤ 0.05)
Means within row and within treatment group lacking a common superscript are significantly different (P ≤ 0.05)

Table 2.2

2

1

Controlled internal drug release
Gonadotropin releasing hormone
3
Human chorionic gonadotropin
4
Day of embryo transfer
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a,b,c

1

Serum samples taken 15 minute apart on each day

x,y

Concentrations of PGF2α (LSMean ± Std Err; ng/mL) for days 7 and 14 in pregnant and non-pregnant cows

Means within the same column lacking a common superscript are significantly different
Means within row and within treatment group lacking a common superscript are significantly different (P ≤ 0.05)

Table 2.3
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Figure 2.1

Concentrations of Plasma Progesterone between Pregnant and NonPregnant Cows on Days 0, 7 and 14

*P ≤ 0.05 between pregnant and non-pregnant cows

Figure 2.2

Concentrations of Plasma Progesterone in the Treatment Groups on Days 0,
7 and 14

Treatment by day, P ≤ 0.05 concentration of progesterone decreased in cows from all treatments from d 7
to d 14; CIDR= controlled drug release; GnRH= gonadotropin releasing hormone; hCG= human chorionic
gonadotropin
* P ≤ 0.05 in the hCG group on d 7 compared to all other treatments
†P ≤ 0.05 in the GnRH group from d 0 to d 14
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Figure 2.3

Concentrations of TNF-α in the Treatment Groups on Days 0, 7 and 14

Treatment by day, P ≤ 0.05; CIDR= controlled drug release; GnRH= gonadotropin releasing hormone;
hCG= human chorionic gonadotropin
†P ≤ 0.05 in the hCG group from d 0 to d 14
*P ≤ 0.05 in the hCG group compared to the GnRH group on d 0

Figure 2.4

Concentrations of TNF-α between Pregnant and Non-Pregnant Cows on
Days 0, 7 and 14

Pregnancy status x day interaction, P ≤ 0.05; CIDR= controlled internal drug release; GnRH= gonadotropin
releasing hormone; hCG= human chorionic gonadotropin.
*P ≤ 0.05 between non-pregnant and pregnant animals on d 0

†P ≤ 0.05 in the non-pregnant group from d 0 to d 14
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CHAPTER III
FUNCTIONAL GENOMICS OF PATERNAL INFLUENCE ON EARLY BOVINE
EMBRYO

Abstract
Understanding molecular mechanisms of early embryonic development and fetalmaternal recognition is critical for better understanding and improving pre- and postimplantation processes in mammals. The objectives of this study were to identify paternal
effects of MHC during early bovine embryogenesis and determine expression levels of
magel2 transcripts in in vivo vs. in vitro embryos sired from low and high fertility bulls as
well as to determine main pathways by which these proteins regulate early development.
Real time reverse transcriptase reaction and bioinformatics approaches were performed,
respectively, to accomplish these goals. There was a significant difference (P ≤ 0.05) in
expression of mhcI transcripts between in vivo embryos from low and high fertility bulls
with the latter having higher expression levels. Interactions (P ≤ 0.05) were also observed
between high fertility in vivo embryos and high and low fertility in vitro embryos.
Magel2 results showed an increase (P ≤ 0.05) in expression levels of high fertility in vivo
embryos compared to their high fertility in vitro counterparts and to low fertility in vivo
embryos. Interactions were also observed between low fertility in vivo embryos had
higher expression (P ≤ 0.05) than high fertility in vitro embryos and high fertility in vivo
embryos having greater expression (P ≤ 0.05) than low fertility in vitro embryos. These
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differences in gene expression influenced by culture environment can have an impact on
developmental potential of pre-attachment embryos.
Keywords: cattle, mhc1, magel2, fertility, paternal, influence
Introduction
The developmentally competent blastocyst communicates to the endometrium to
advance attachment using newly synthesized transcripts and proteins. Since an embryo
can carry both sets of maternal and paternal genes, it may be considered an antigen by the
maternal immune system. This semi-allogeneic conceptus is a stranger that needs to bypass several immunological and endocrinological barriers in the maternal immune system
[30].
Three classes of Major Histocompatability Gene Complex (MHC) have been
identified as MHC class I, MHC class II, and MHC class III thus far in mammals. Major
Histocompatability Gene Complex express highly polymorphic cell surface antigens,
playing an essential role in immune response by distinguishing the differences between
self and non-self-molecules including graft rejection at the feto-maternal intersection
[35]. Major histocompatibility complex I is classified into two groups; classical and nonclassical. It is believed that the lack of classical MHC I expression is protection for the
placenta against immune attacks [43]. In addition to classical MHCI, non-classical MHCI
is less polymorphic and have different functions that protect the embryos from immune
cells, making its expression beneficial to embryo survival and pregnancy.
Although MHC I may be instrumental in the process of maternal rejection, it is
not the only gene whose product influences embryo development or the efficiency of the
offspring later in life. Expression patterns of imprinted genes, as in magel2, are
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vulnerable during the pre-attachment stage [78]. MAGEL2 is responsible for the PraderWilli Syndrome (PWS). This deficiency affects reproduction by causing hypogonadism
in males with deficient magel2 expression in the hypothalamus. Mercer et al. [106] found
that an increase in age of magel2-null male mice show a decrease in the pregnancy rates
of their female partners. In that same study, concentrations of testosterone were lower in
magel2 null mice. This suggests that magel2 has an effect on the hypothalamic release of
gonadotropin releasing hormone (GnRH). If GnRH is decreased the amount of luteinizing
hormone (LH) released from the stimulated pituitary gland would be decreased as well
thereby reducing testosterone levels. This theory is supported by [256] who observed
abnormalities of the hypothalamic-pituitary axes created by magel2 null mice and that
magel2 is required for the negative feedback system that regulates the endocrine system
via the hypothalamus. Magel2 may also indirectly play a role in infertility via PWS as
this disease causes extreme obesity in both animals and humans. Magel2 null mice
weighed less at weaning, but increased their weight dramatically [107]. Obesity and
infertility go hand- in- hand as it can cause erectile dysfunction and hormonal
dysfunctions [108-110].
In vitro produced bovine embryos express both classical and non-classical MHC
class I genes [74]; however, the mechanism and their interactions with other molecules
are not known. Therefore, molecular mechanisms of how MHCI regulates developmental
potential and increases pregnancy rates through immunosuppressive functions are
completely unknown in mammals. Furthermore, the role of magel2 in PWS or its specific
function that causes reduced fertility in males remains a mystery.
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The purpose of this study was to identify paternal effects of MHC during early
bovine embryogenesis and determine expression levels of magel2 in in vivo vs. in vitro
embryos sired from low and high fertility bulls as well as to determine main pathways by
which these proteins regulate early development
Materials and Methods
Fertility differences among the bulls
Fertility scores were determined as a SD from the average fertility values of
approximately 1,000 bulls. Fertility results of one high and one low-fertility bull are
summarized in Table 3.1 for the in vivo embryos and fertility scores of the in vitro
embryos are presented in Table 3.2. The ranking of the bulls was done using their fertility
scores obtained from Alta Advantage Program (Alta Genetics, Watertown, WI, USA),
where the fertility of bulls are predicted quarterly using updated data from partnering
herds. Briefly, the average fertility was assigned to be zero=0; thus, scores above this
value were considered high fertility and defined as positive values while below average
were defined as negative (-) values and named as low fertility bulls.
In vitro Maturation of Bovine Oocytes (IVM)
Immature oocytes were aspirated from their follicles in ovaries of 2 to 8 mm
sizes, washed three times in Tyrode’s lactate-HEPES (Sigma-Aldrich Co, St. Louis, MO
USA) and transferred in to maturation media consisting of Tissue Culture Medium
(TCM) 199 (Invitrogen, Carlsbad, CA USA). Fifty oocytes were cultured into 500 µL
maturation media and shipped to our laboratory at 39ºC within 24 h following the start of
maturation [257].
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In vitro Fertilization of Bovine Oocytes (IVF):
Fertilization was performed according to [257]. Briefly, mature oocytes were
washed with TL-HEPES and transferred into fertilization medium (Millipore, Danvers,
MA USA). Percoll (Sigma-Aldrich Co.) gradient solution was used for separation of live
spermatozoa from frozen–thawed semen and diluted spermatozoa with TL-HEPES was
added into the fertilization drops and was incubated for 18 h in the incubator in the same
gas condition. Table 3.3 shows the in vitro blastocysts derived from six bulls of varying
fertility.
Culturing embryos in vitro and collection of blastocysts
All presumptive zygotes were transferred into 50 µL of synthetic oviduct fluid
(SOF, Millipore) under mineral oil (30 zygotes per drop). Cleavage rate (ratio of zygotes
reached to 2-cell stage) was evaluated at 48 hpi and 96 hpi (8-cell stage), then cleaved
embryos were kept under the same culture conditions, but with the addition of fetal
bovine serum (FBS, Gibco/Invitrogen, Carlsbad, CA USA) toward blastocyst stage. All
blastocysts from each group were individually collected into the 600 µL eppendorf tubes
(Eppendorf, Hauppauge, NY USA) and frozen at -80ºC until RNA isolation [258]. All
Blastocysts derived from these six bulls with 4 replicates were listed in Table 3.3.
Collection of in vivo embryos
Ten non-lactating Brangus cows were initially synchronized for estrus. A CIDR
(Eazi-Breed™ CIDR®; Zoetis, Madison NJ) was inserted and removed 7 d later. One d
after removal of the CIDR, all cows were administered an injection of PGF2a (25 mg IM;
Lutalyse; Zoetis). This was followed by superovulation via an initial injection of 2 cc of
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GnRH (100 µg, IM; Cystorelin; Sanofi Winthrop, Bridgewater, NJ USA) and sequential
and declining amounts of Follitropin (50 mg, IM; Bioniche, Belleville, ON Canada) over
the subsequent four d (1.6 cc to 0.4cc respectively). Artificial insemination occurred 12
and 24 hr after standing estrus was observed. Sperm from one of two bulls (1 low fertility
and 1 high fertility) was randomly inseminated. Seven d later, embryos were flushed,
graded and cryopreserved in ethylene glycol and stored in liquid nitrogen until their use.
All in vivo embryos used for this study were grade 2 and stage 4.
Thawing of embryos
In vitro embryos used in this study had been previously prepared and were
already RNA isolated/cDNA (complimentary DNA) converted and stored in the -80°C
freezer. In vivo embryos were thawed by removing the vials with blastocysts from the
liquid nitrogen and air thawed for 10 seconds. Blastocysts were then incubated in thaw
solution 1 (Dulbecco’s Modified Phosphate-Buffered Saline (DMPBS), 0.5M sucrose,
5% glycerol) for five minutes, followed by the submersion of blastocysts in thaw solution
2 (DMPBS, 0.5M sucrose, 2.5% glycerol) and thaw solution 3 (DMPBS, 0.6M sucrose,
0% glycerol) for five minutes each, and finally held in the holding medium (0.4% BSA
in PBS). Directly after thawing RNA was isolated from blastocysts.
Isolation of RNA from in vivo and in vitro developed blastocysts
RNA isolation was performed using the PicoPure Rneasy Kit (Qiagen, Valencia,
CA USA) according to the manufacturer’s instructions. Total RNA was isolated,
individually, from sixteen blastocysts from in vivo embryos derived by two different bulls
(1 low fertility and 1 high fertility bull) and from sixteen blastocysts from in vitro
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embryos derived from two different bulls (1 low fertility and 1 high fertility). The
quantity and purity of the RNA samples were determined by NanoDrop ND-1000
spectrophotometer (NanoDrop Tech., Wilmington, DE USA).
Confirmation of paternal influence of MHC and MAGEL2 gene expression by Realtime reverse transcriptase polymerase chain reaction (real-time RT-PCR)
The RT-PCR was performed as previously described [133]. RNA was converted
into cDNA by using Platinum III two step kit (Invitrogen Life Technologies, Carlsbad,
CA USA) according to the manufacturer’s protocol. The cDNA was used for quantitative
real-time PCR amplification with the SYBR Green I kit (Invitrogen Life Technologies) in
the RT-PCR machine (Stratagene-Agilent Technologies, Inc.- MX3005 P, La Jolla, CA
USA). The locus specific primer sets for MHC I were designed for the non-classical
MHC-I genes (NC1-4) by [141] and were used for amplifications. The internal
housekeeping gene, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation
protein, zeta polypeptide (YWHAZ), was used to normalize the results according to
[258]. The thermal cycling parameters (95°C for 2:00 min, 95°C for 15 sec, 60°C for 30
sec, and 72°C for 30 sec for 40 cycles) were used to detect the expression of target genes.
All amplification experiments were repeated three times and the information for all
primers are listed in Table 3.4.
Using a primer for magel2, we were able to detect both cDNA and gDNA
(genomic DNA). To prevent contamination of our findings, magel2 was examined with
endpoint PCR in sperm gDNA, cow gDNA, placental cDNA, and multiple blastocysts. A
1.5% agarose gel was run to confirm that no gDNA contamination had occurred, as can
be seen in Figure 3.1. It is also noteworthy that there was an attempt to examine the IGF2
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maternally imprinted, paternally expressed gene. However, when using endpoint PCR to
verify the primers the only signal detected to confirm the presence of IGF2 was when
multiple blastocysts were used and not from single blastocysts (Figure 3.2), which was
the purpose of this study.
Computational Biology Approaches:
Protein Sequences
Protein sequences for MHCI for bovine, mouse, human, opossum, and lowland
gorilla were obtained from the UniProtKB (www.uniprot.org) database and saved into
FASTA format. Golden starred sequences indicating Swiss-Prot, which is manually
annotated and reviewed, were used when available in this study. The same approach was
used for MAGEL2 in reference to the following species; human, mouse, bovine, and
rhesus macaque.
Multiple Sequence Alignment
Protein sequences previously obtained from UniProt were aligned using Clustal
W2. Sequences were input to the Clustal W2 database
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) and scored using the system default
parameters.
Phylogenetic Trees
Phylogenetic and molecular evolutionary analyses of the MHCI protein in mouse,
bovine, human, lowland gorilla, and opossum were conducted using MEGA version 5
[259]. The protein sequences were converted from the FASTA format mentioned above
to a MEG format to be loaded into the program and a multiple sequence alignment was
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created. Following the sequence alignment, trees were built using the Neighbor joining
method with 500 bootstrap replicates. The same approach was followed for the MAGEL2
protein in human, mouse, bovine, rat, pig, and ferret species.
Domain Conservation and Identification of Functional Motifs
Using the Pfam 24.0 database (http://pfam.sanger.ac.uk/), functional motifs and
conserved domains were identified for MHCI proteins for bovine, mouse, opossum,
human, and lowland gorilla. The same was completed for MAGEL2 proteins for human,
bovine, mouse, and Rhesus monkey species. Query for the sequences were loaded into
the database. Data of the query resulted in information on the family, description, clan,
and location of identified domains for each protein.
Ingenuity Pathway Analysis
To gain insights into the biological pathways and networks associated with our
two proteins, we used Ingenuity Pathways Analysis (IPA; Ingenuity Systems, California).
We inserted the gene name and selected the appropriate gene from the list that IPA
provided after its search. Following the selection, a summary of the gene was given
showing all of the information currently known about the specific inquiry (Table 3.5). A
list of potential canonical pathways and interaction networks were then presented.
Canonical pathways and interaction networks are created by proteins of interest being
corresponded to gene objects in the Ingenuity Pathway Analysis Knowledgebase (IPAK).
This knowledgebase is acquired through published, peer reviewed literature; thereby
allowing IPA to build networks of interacting proteins. The confidence level used in each
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protein was based on experimental observation, high predication, and moderate
predication with direct and indirect interactions being applied.
Statistical Analysis
Data were obtained from 3 technical replicates for the qPCR experiments with
magel2 and yhwaz (control gene) in the in vivo and in vitro embryos, with two technical
replicates for mhcI in the in vivo and in vitro embryos. Statistical data was analyzed using
the one-way ANOVA procedure (SAS, Inst. Inc., Cary, NC). All comparisons in the
statistical analysis were established at a 5% level of significance.
Results and Discussion
Dynamics of MHCI and MAGEL2 expression in blastocysts
The calibrator chosen for this study was five randomly chosen embryos. The
amount of our target genes, mhcI and magel2, were normalized to the internal control
gene yhwaz and relative to the calibrator. A linear fit with a slope between approximately
-3.1 and -3.6, equivalent to a calculated 90-110% reaction efficiency, is typically
acceptable for most applications requiring accurate quantification [260].
In contrast to human and mice, knowledge about MHC1 in bovine is limited.
Several studies have investigated mhcI during pregnancy in cattle and fewer have
investigated its expression in pre-attachment embryos. In our study, a higher expression
(P ≤ 0.05) of mhcI in high fertility in vivo embryos was seen when compared to their low
fertility in vivo counterparts (Figure 3.3). Non-classical MHCI is expressed by
trophoblasts in binucleate cells [71]. This is important because these cells are extruded
through the maternal side of the placenta where they fuse with the maternal endometrial
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cells to form feto-maternal units. These units are known to secrete hormones involved in
maintenance of pregnancy, but they may also have an immunological function. Several
studies have indicated MHCI role in the maternal immune system and the importance of
non-classical MHCI production to inhibit the lymphocytes attacking the embryo [44, 45].
Our results suggest that high fertility bulls are able to produce more immunologically
stable embryos, which presents the opportunity of using MHCI as a potential sperm
fertility biomarker. Culture was also a main effect as high fertility in vivo embryos had a
greater expression (P ≤ 0.05) than high fertility in vitro embryos. An interaction was
observed between culture and fertility. High fertility in vivo embryos had greater
expression (P ≤ 0.05) levels than low fertility in vitro embryos. Although the difference
in expression level may be attributed to fertility, it has been previously reported that in
vitro embryos expressed higher levels of mhcI and may lead to greater pregnancy rates
[74]. Several investigators have reported that mhcI expression is regulated via the
promoter region of the gene, which can be regulated by different cytokines [261, 262].
Interleukin-1 (IL-1) and interferon-gamma (IFN-γ) are two cytokines that are known to
be detrimental to the success of pregnancy and have also been shown to enhance embryo
development and survival when added to the culture media of in vitro embryos [263].
However, our study suggests that in vivo embryos have greater expression of mhcI
compared to in vitro embryos, indicating that in vitro culture may not provide the extra
sustenance for immunologically improved embryos.
High fertility in vivo embryos had higher expression (P ≤ 0.05) levels of magel2
than high fertility in vitro embryos (Figure 3.4). This suggests that the culture used for
IVF may interrupt the imprinting process, as it was discovered with the loss of imprinting
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gene H19 in murine embryos fertilized in Whitten’s medium [264]. Epigenetic
modification, such as DNA methylation, can affect gene expression and genomic
imprinting is controlled by this phenomenon in a way that only one parental allele will be
expressed [77, 79]. It has been suggested that exposing early embryos to in vitro culture
can cause alterations in transcription and methylation patterns, disrupting the epigenetic
control of genes [265]. This is supported by the large offspring syndrome found in cattle
and sheep caused by an abnormal methylation pattern of the IGF2R gene experienced in
in vitro embryos [266]. High fertility in vivo embryos also had a greater expression (P ≤
0.05) than their low fertility in vivo counterparts. This result again supports the theory
that high fertility bulls may have a more significant methylation pattern compared to low
fertility bulls. Additionally, interactions (P ≤ 0.05) between culture and fertility were
observed. Low fertility in vivo embryos expressed higher levels of magel2 than high
fertility in vitro embryos. Although unclear if it the culture or the fertility that is affecting
the interaction, speculation can be made that it is the culture as high fertility embryos
would be expected to have higher expression levels. A second interaction was observed
with high fertility in vivo embryos expressing higher levels of magel2 than low fertility in
vitro embryos (Figure 3.4). Again, it is unclear if it the culture or fertility that is affecting
the results, however, these observations further support the notion that IVF culture can
cause an interruption in methylation patterns during development.
Computational Biology
Evolutionary Comparison
The evolutionary history of the MHCI protein (Figure 3.5) between mouse,
bovine, human, lowland gorilla and opossum species was inferred using the Neighbor57

Joining method. The percentage of replicate trees in which the associated taxa clustered
together in the bootstrap test (500 replicates) are shown next to the branches. The tree is
drawn to scale, and is a representation of the bootstrap consensus tree. In the MHCI
protein tree the results show that human and lowland gorilla share a branch, bovine and
mouse share a branch, while the opossum is on a branch of its own. Figure 3.5 shows that
human and lowland gorilla were similar 95% of the time during replication for the MHCI
protein and are highly conserved, bovine and mouse were similar 63% of the time during
replication, and the opossum is on a branch of its own due to its lack of evolution. The
MAGEL2 results show that mouse and rat had a 100% bootstrap value, indicating an
extremely high level of occurrence during replication. On the other hand, we cannot be as
confident in the human and ferret clade because it only had a 36% bootstrap value,
suggesting that the human/ferret occurrence was low during replication (Figure 3.6).
Only mouse and human sequences were obtained with Swiss-Prot. Although ferret and
bovine sequences were determined as uncharacterized proteins (lacking an assigned
cellular function), they were chosen by the length of their sequences to compare to other
species and to increase bootstrap replicates.
Domain Conservation
Results from the Pfam analysis of the MHC1 protein (Table 3.7) showed that each
species query produced varying information for several families (MHC I, C1-set, and
MHC_I C) within the mhcI gene. There was no conservation of domain location or
motifs between the species aside from the human and lowland gorilla. These two species
showed a high conservation in both domain with the same start and end locations and
functional motifs with similar bit scores (difference of 1.3) for the MHCI family.
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Moderate conservation was also seen between human and lowland gorilla species in the
C1-set and MHC_I C families, although bit scores differed suggesting that the protein
sequence differed, but functionality was the same. Data on domain conservation for
MAGEL2 (Table 3.8) produced some similar results to MHCI. Each species protein
query identified MAGEL2 as part of the MAGE family in the bovine, mouse, human, and
Rhesus monkey. Two species, bovine and Rhesus monkey, showed a highly conserved
domain location, however, the bit scores differed slightly. The difference in score is
indicative of the species not having the same protein sequence yet functionality of the
protein is the same. There were no predicted active sites for MHCI or MAGEL2.
Modeling using Ingenuity Pathway Analysis
Allograft Rejection Signaling Pathway
Although there are multiple pathways and microRNA’s (miRNA) related to
MHCI (Table 3.6), one particular pathway is of particular interest to the immune
response of the mother during attachment (Figure 3.7). The allograft rejection-signaling
pathway provides insight into the possible maternal immune system reaction between
mother and conceptus during attachment. By providing a visual aid of the proteins
possible role in early embryonic development this map further supports the hypothesis
that proper MHCI expression is integral to the survival of the embryo.
The classical form of MHCI expresses highly polymorphic cell surface antigens,
which play an essential role in immune response by distinguishing the differences
between self-vs. non-self-molecules including graft rejection at the feto-maternal
intersection [35]. Since an embryo can carry both sets of maternal and paternal genes, it
may be considered an antigen by the maternal immune system [29]. Several studies have
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shown that the expression of classical MHCI during early pregnancy results in loss of the
embryo [60]. The MHCI classical proteins present peptides to T-cell receptors on CD8+
cytotoxic-suppressor T lymphocytes [267]. Most T-cells express T-cell receptors that
recognize antigens. Antigens are bound to classical MHCI proteins and brought to the
surface where they can be recognized by T-cells. If the T-cell receptor is specific for that
antigen it binds to the complex of MHCI and destroys the cell via glycoprotein CD8+. It
is believed that the lack of classical MHCI expression is a protection mechanism of the
placenta against immune attacks [268]. In addition to classical MHCI, non-classical
MHCI has less polymorphism and different functions that protect embryos from immune
cells. Non-classical MHCI proteins are monomorphic and act as ligands for inhibitory
leukocyte receptors; including natural killer cells [44, 45]. Expression of non-classical
MHCI proteins by the trophoblast is believed to inhibit activation of uterine leukocytes
and protect the conceptus. Our results support this as greater non-classical mhcI
expression was seen in high fertility rather than low fertility sires.
Interaction Network for MAGEL2
No known canonical pathways exist for MAGEL2 within IPA, however, a list of
miRNAs (Table 3.6) and the interaction network model (Figure 3.8) have been developed
that gives an interesting view into MAGEL2 relationship with fertility. By utilizing the
interaction network we were able to visualize the direct relationship between MAGEL2
and other genes and miRNAs involved in fertility and early embryonic development.
One of the miRNAs directly related to MAGEL2 is also a target for another
imprinted gene that is known to affect fertility. MicoRNA1273 that is associated with
MAGEL2 also targets the paternally imprinted IGF-1 and IGF-2 genes; known to affect
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placenta morphology [269]. Other genes and miRNA directly related to MAGEL2 that
are thought to be involved in fertility are tripartite motif 27 (TRIM27), and miRNA1403p. Tripartite motif 27 is a gene thought to be involved in the differentiation of male
germ cells [270]. Although TRIM27 role is unclear, the process of spermatogenesis is
imperative to male fertility as any morphological or genetic defect within the male
haploid cell can cause irreparable damage to the fertility of a bull. MicroRNA 140-3p is
expressed in developing testis and involved in gonad differentiation[271]. Genes
identified and targeted by this miRNA are known to play a role in gonad development
and regulate the expression of factors expressed by Sertoli and Leydig cells [271-273].
No information was available in IPA to create a canonical pathway for this protein,
however, its direct relationship with other genes and miRNAs involved in fertility and
early embryonic development suggests that MAGEL2 is more involved in successful
pregnancies than predicted.
Our results showed that high fertility sires have a greater expression of mhcI
compared to low fertility sires within an in vivo environment. This suggests that high
fertility bulls are able to produce more immunologically stable embryos and gives
potential insight regarding the impact of male fertility on embryo survival. The difference
in mhcI expression levels between high and low fertility implies the idea that regulation
of paternal genes during development is imperative for embryo survival. These results
also suggest the use of non-classical MHCI as a potential marker for male fertility. The
higher expression level of magel2 experienced by in vivo embryos suggest a lower
chance of developing Prader-Willi syndrome compared to in vitro derived embryos,
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perhaps through the establishment of uninterrupted methylation patterns for imprinted
genes during development.
Table 3.1

Fertility scores of High and Low Fertility Bulls for the in vivo Embryos

List of bulls and their fertility scores according to Alta Genetics data base including bulls’ breeding
numbers. Bulls are listed according to their fertility scores where bull 1 is considered to be highly fertile
and bull 2 is a low fertile bull.

Table 3.2

Fertility scores of High and Low Fertility Bulls for the in vitro Embryos

List of bulls and their fertility scores according to Alta Genetics data base including bulls’ breeding
numbers. Bulls are listed according to their fertility scores where bull 1 is considered to be highly fertile
and bull 2 is a low fertile bull.

Table 3.3

In vitro blastocysts derived from six bulls of varying fertility

Lists of the bull groups that were used to create in vitro fertilized embryos that had varying fertility. The
groups of bulls were designed so that Group A had the lowest fertility and Group F had the highest fertility.
Group B blastocysts from trial 1 (1/3/2011) on day 7 were used as our low fertile blastocysts and Group F
from trial 1 (1/3/2011) on day 7 were used as our high fertile blastocysts.

62

Table 3.4

Reverse transcription-polymerase chain reaction primers

Gene

Primer (5’

MAGE-like
(MAGEL2)

3’)

GenBank Lengt Sourc
Accession h (bp) e
No.
AY94855 257 [144]
1

Forward:
CTGATGGTGGTTCTGAGCCT
Reverse:
CAGGACAATCATCTTGCTGG
BOLA-NC1
Forward:
510417 341 [141]
Non-classical MHC class TTGTGGAGACCAGGCCTTCAG
I antigen
Reverse:
GAGAACCAGGCCAACAATGATG
+
AGGAGAACCAGGACAAGAATGA
TG
Tyrosine 3Forward:
BM44630 120 [134]
monooxygenase/tryptoph GCATCCCACAGACTATTTCC
7
an 5- monooxygenase
Reverse:
activation protein, zeta
GCAAAGACAATGACAGACCA
polypeptide (YHWAZ)
Two reverse primers were combined for MHC 1 as stated in [71]. List of the genes used in this study and
their forward and reverse primers are available. The GenBank accession number, base pair length, as well
as other references used to verify our own study are listed for verification purposes
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HLA-C
IFN-gamma

Regulates

Protein
Function
Cytosolic tail
domain

Gene Summary of mhc1 and magel2
Cellular
Processes
Induction of
cytotoxic T cells,
naive
lymphocytes and
naïve T
lymphocytes

Molecular
Mutant
Processes
Information
Concentrations of Protein
Ca2+
Substitution

Top Diseases

Adenocarcinoma
Susceptibility to
HIV-1
IL-6
Production of
DNA SNP
Endometrosis
immunoglobulin Substitution
TAP2
Acquired
Mutation
immunodeficiency
syndrome
B2M
Immunoglobulin Stimulation of
Disassociation of Missense
Rheumatoid
domain
leukocyte cell
B2M, HLA-C,
arthritis
lines
TAP2, protein
TNF
Duchenne
fragment
muscular
dystrophy
Immunoglobulin
Retention of
Psoriasis
2+
HLA-C
Ca
Cancer
magel2
Hormone
Protein binding Unknown
Unknown
Autosomal
Prader-Willi
dominant
Syndrome
D-Glucose
A summary of the two genes in this study was compiled through the ingenuity pathway analysis system. It provides the function of
the protein and what it regulates, its cellular and molecular processes, mutant information, and the top diseases associated with
dysfunctions of the gene.

mhcI

Gene

Table 3.5
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Allograft Rejection Signaling
Antigen Presentation Pathway
Autoimmune Thyroid Disease Signaling
Caveolar-mediated Endocytosis Signaling Cdc42 Signaling
Communication between Innate and Adaptive Immune Cells
Crosstalk between Dendritic Cells and Natural Killer Cells
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells
Dendritic Cell Maturation
Graft-versus-Host Disease Signaling Neuroprotective Role of
THOP1 in Alzheimer's Disease
OX40 Signaling Pathway
Protein Ubiquitination Pathway
Systemic Lupus Erythematosus Signaling
Type I Diabetes Mellitus Signaling
Virus Entry via Endocytic Pathways










miR-4660
miR-4675
miR-4758-3p
miR-4787-5p
miR-491-5p
miR-541-3p
miR-542-5p
miR-764
miR-767









miR-1188-3p
miR-1301
miR-148b-3p
miR-149-3p
miR-4302
miR-4462
miR-4635

Top Targeted miRNAs

 miR-4502
 miR-1273f
 miR-4636
 miR-140-3p
MAGEL2
No Known Canonical Pathways
 miR-4697-3p
 miR-182-5p
 miR-4728-3p
 miR-21-3p
 miR-4733-3p
 miR-221-3p
 miR-4757-5p
 miR-3677-5p
 miR-4766-5p
 miR-3682-5p
 miR-589-5p
 miR-4435
 miR-873-5p
The pathways and microRNAs associated with both MHC1 and MAGEL2 were found via the ingenuity pathway analysis software. It provides a list of direct
and indirect pathways and interactions associated with its respective protein. MAGEL2 has no known canonical pathways, but has miRNAs that are related to
fertility and imprinted genes, while MHC2 has multiple pathways and miRNAs.

MHC I











Top Canonical Pathways

Canonical Pathways and miRNAs associated with MHC1 and MAGEL2

Protein

Table 3.6
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Family

Description

Domain Conservation and Motif Functionality of MHC1

Entry
Envelope
Alignment
HMM
Bit Score
E-Value
Predicted Active
Type
Sites
Start
End
Start
End From
To
Bovine
MHC1
Class I Histocompatability Domain
22
200
22
200
1
179
314.9
1e-94
n/a
antigen, domains alpha 1
and 2
C1-set
Immunoglobulin C1-set Domain 209
292
216
297
7
82
75.1
3e-21
n/a
Domain
MHC_IC
MHC_IC terminus
Family
331
359
331
359
1
29
55.7
2.2e-15
n/a
Mouse
MHC1
Class I Histocompatability Domain
1
106
1
92
1
92
153.8
2.8e-45
n/a
antigen, domains alpha 1
and 2
C1-set
Immunoglobulin C1-set Domain
92
179
104
178
8
82
70.7
7.4e-20
n/a
Domain
MHC_IC
MHC_IC terminus
Family
220
245
220
245
1
29
42.0
4.5e-11
n/a
Opposum
MHC1
Class I Histocompatability Domain
1
98
1
98
83
179
135.4
1.3e-39
n/a
antigen, domains alpha 1
and 2
C1-Set
Immunoglobulin C1-set Domain 107
190
116
189
8
82
69.1
2.4e-19
n/a
Domain
MHC_IC
MHC_IC terminus
Family
228
256
228
255
1
28
55.3
3e-15
n/a
Human
MHC1
Class I Histocompatability Domain
25
203
25
203
1
179
323.8
1.8e-97
n/a
antigen, domains alpha 1
and 2
C1-set
Immunoglobulin C1-set Domain 209
295
219
294
7
82
73.4
1e-20
n/a
Domain
MHC_IC
MHC_IC terminus
Family
337
363
338
363
2
27
45.2
4.4e-12
n/a
Lowland Gorilla
MHC1
Class I Histocompatability Domain
25
203
25
203
1
179
322.5
4.6e-97
n/a
antigen, domains alpha 1
and 2
C1-set
Immunoglobulin C1-set Domain 212
295
217
294
5
82
70.8
6.7e-20
n/a
Domain
MHC_IC
MHC_IC terminus
Family
336
364
337
364
2
29
49.2
2.4e-13
n/a
Results from the Pfam analysis of the mhc1 protein showed that each species query produced varying information for several families (MHC I, C1-set, and
MHC_I C) within the mhcI gene. There was no conservation of domain location or motifs between the species aside from the human and lowland gorilla .

Species

Table 3.7
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MAGE

MAGE

MAGE

Human

Mouse

Bovine

MAGE Family

Family

Family

Family

MAGE Family
MAGE Family

Entry Type

Description

n/a

n/a

n/a

Clan

1

265

307

Start

72

435

477

End

Envelope

1

265

307

Start

72

432

477

114

1

1

189

192

95

To

HMM

End From

Alignment

70.9

154.4

175.6

Bit Score

8.4e-20

2.1e-45

7e-5

E-Value

n/a

n/a

n/a

Predicted
Active Sites

n/a
Rhesus
MAGE
MAGE Family
Family
n/a
2
72
2
70
1
85
67.3
1.1e-18
Monkey
Data on domain conservation for MAGEL2 PRODUCED FROM Pfam analysis identified MAGEL2 as part of the MAGE family in the bovine, mouse,
human, and Rhesus monkey. Two species, bovine and Rhesus monkey, showed a highly conserved domain location .

Family

Domain Conservation and Motif Functionality of MAGEL2

Species

Table 3.8
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Figure 3.1

magel2 Confirmation

The magel2 primer was able to detect both cDNA (complimentary DNA) and gDNA (genomic DNA). To
prevent any contamination of our findings we examined magel2 with endpoint PCR in sperm gDNA, cow
gDNA, placental cDNA, and multiple blastocysts. A 1.5% agarose gel was run to confirm that no gDNA
contamination had occurred

.

Figure 3.2

igf2 Confirmation

Along with MHCI and MAGEL2, we attempted to identify the maternally imprinted IGF2 gene in single
blastocysts. However, through endpoint PCR and gel electrophoresis it was determined that signals were
only received from multiple blastocysts and no single blastocysts when using this primer.
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mhc1 Relative Gene Expression between low and high fertility in vivo and
in vitro embryos

Figure 3.3

*P ≤ 0.05 HF in vivo compared to LF in vivo embryo and HF and LF in vitro embryos
The comparisons of mhcI imprinted gene expression between low and high fertility embryos in vivo, low
and high fertility in vitro embryos, as well as a comparison of varying fertility embryos between the in vivo
and in vitro groups were assessed utilizing qPCR.

*

†

Figure 3.4

magel2 Relative Gene Expression of low and high fertility between in vivo
and in vitro embryos

†P ≤ 0.05 LF in vivo compared to HF and LF in vitro embryos
*P ≤ 0.05 HF in vivo compared to LF in vivo and HF and LF in vitro embryos
The comparisons of magel2 gene expression between low and high fertility embryos in vivo, low and high
fertility in vitro embryos, as well as a comparison of varying fertility embryos between the in vivo and in
vitro groups were assessed utilizing qPCR.
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Figure 3.5

MHC1 Phylogenetic Tree

The relationship of the MHCI protein between mouse, bovine, human, lowland gorilla and opossum species
was inferred using the Neighbor-Joining method. The percentage of replicate trees in which the associated
taxa clustered together in the bootstrap test (500 replicates) are shown next to the branches. The tree is
drawn to scale, and is a representation of the bootstrap consensus tree.

Figure 3.6

MAGEL2 Phylogenetic Tree

The relationship of the MAGEL2 protein between mouse, bovine, human, rat and ferret
species was inferred using the Neighbor-Joining method. The percentage of replicate
trees in which the associated taxa clustered together in the bootstrap test (500 replicates)
are shown next to the branches. The tree is drawn to scale, and is a representation of the
bootstrap consensus tree bootstrap consensus tree bootstrap consensus tree
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.
Figure 3.7

Allograft Rejection Signaling Pathway for MHC1

The allograft rejection signaling pathway was created using the ingenuity pathway
analysis software system. Out of the list of possible pathways for MHCI, this particular
pathway provides insight into the possible maternal immune system reaction between
mother and conceptus during implantation.
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Figure 3.8

Interaction Network for MAGEL2

We were able to create an interaction network for MAGEL2. This protein has multiple
direct and indirect relationships with genes and miRNAs and the interaction network
helps to visualize the multiple relationships that MAGEL2 has with these genes and
miRNA’s and their possible effects on fertility.
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CHAPTER IV
CONCLUSION

Fertility is the capability to produce offspring. The development of gametes, the
ability of the sperm to fertilize the egg, maternal recognition of pregnancy, and early
embryonic development are all crucial events that must occur for a successful pregnancy.
There are a number of calculating factors that influence fertility. Male fertility is
considered to be the fertilizing ability of sperm to activate the oocyte and to support early
embryonic development. Male fertility is vital for propagation of species through sexual
reproduction, and is influenced by sperm abnormalities (compensatory and noncompensatory), structural abnormalities (damage or blockage of the testes or tubes),
hormonal deficiencies, and genetic disorders or dysfunctions that are all detrimental in
fertilization or early embryonic development. Male infertility is an essential factor
limiting efficient production in the cattle industry due to the lack of reliable, noninvasive
markers to predict semen quality and bull fertility.
Effects of Progesterone on Embryo Survival
Progesterone plays an essential role during pregnancy and is widely viewed as
critical for embryo survival and establishment of pregnancy [230, 231]. However,
molecular mechanisms by which progesterone improves the survival of transferred
embryo in the uterus are not known. Results from the first study suggest that high
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concentrations of progesterone on d 14 after the transfer are imperative to the survival of
transferred embryos. Studies done by other researchers support our findings by revealing
embryonic losses of 40% in embryo transfer programs during the first 18 days of
gestation in sheep and cattle [274]. Concentrations of progesterone on d 7 are also
suggested to be critical to embryo survival [212]. A second outcome of this study
suggests that an increase in concentration of progesterone inhibits the luteolytic effects of
TNF-α. These results are in line with previous research conducted in our lab and that
suggest luteotropic roles of TNF-α in CL function throughout the estrous cycle [171,
209]. Lastly, concentrations of PGF2α metabolite were observed to be greater on d 14 in
both non-pregnant and pregnant animals. Interestingly, other investigators [247-250] also
found that PGF2α has similar concentrations in non-pregnant and pregnant animals. For
the mechanism, this suggests that the pattern of uterine secretion is altered during
pregnancy and that greater concentration of PGF2α become luteo-protective via lowered
sensitivity or increased release of PGE2α [251].
Paternal Effect on Early Embryonic Development
Maternal rejection of conceptus has been associated with a change in hormone
levels, improper secretion of cytokines, or the lack or over expression of genes, and all of
these indiscretions result in a loss of embryo [275]. Since the actual reason of maternal
rejection has not been completely understood, to what extent early mammalian embryo
development is paternally affected is not fully clear. Our results suggest that high fertility
bulls have greater expression of mhcI than their low fertility counterparts in in vivo
embryos, suggesting that mhcI could be used as a fertility marker. Magel2 expression was
greater in in vivo embryos compared to in vitro embryos. These findings support the idea
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that DNA methylation patterns play key roles in both fertility and environment for
gametes. DNA methylation is indispensable for genome function. Defective methylation
patterns may result in lower fertile bulls having insufficient production of MHCI and in
vitro culture may interrupt the methylation pattern of imprinting genes. Lastly,
computational biology analysis revealed a role for MHCI in the maternal immune
response via the allograft rejection signaling pathway as suggested by [35].
The present need to improve production efficiency in the cattle industry parallels
the increase in global population. The quality of genetics in a herd is a factor highly
associated with production efficiency and consequently influences the profitability of the
livestock industry. Animals that grow and reproduce quickly are key components for
profitability of livestock operations. At present, embryo transfer is perhaps the best
avenue to rapidly improve the genetics of cattle. Despite the benefits, the technique is not
as widely used as artificial insemination in the cattle industry, due to embryo mortality.
The potential impact of this line of research in the livestock industry is of immense value
and extremely important to strengthen animal reproduction. Once the role(s) of
progesterone in regards to the survival of the transferred embryos are identified, it will
then be possible to manipulate synchrony between the embryo and the uterine
environment to enhance survival of transferred embryos in cattle. To help with the
development of these young embryos, the use of immunologically and reproductive
competent blastocysts are greatly required. In the future, the ability to determine embryo
quality by the use of biomolecular markers will increase the benefits both to consumers
and producers.
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